Global vascular guidelines on the management of chronic limb-threatening ischemia

Fowkes, 2013, Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, 382, 1329, 10.1016/S0140-6736(13)61249-0

Goodney, 2013, Regional intensity of vascular care and lower extremity amputation rates, J Vasc Surg, 57, 1471, 10.1016/j.jvs.2012.11.068

Goodney, 2014, Relationship between regional spending on vascular care and amputation rate, JAMA Surg, 149, 34, 10.1001/jamasurg.2013.4277

Abu Dabrh, 2015, Nonrevascularization-based treatments in patients with severe or critical limb ischemia, J Vasc Surg, 62, 1330, 10.1016/j.jvs.2015.07.069

Abu Dabrh, 2015, The natural history of untreated severe or critical limb ischemia, J Vasc Surg, 62, 1642, 10.1016/j.jvs.2015.07.065

Abu Dabrh, 2016, Bypass surgery versus endovascular interventions in severe or critical limb ischemia, J Vasc Surg, 63, 244, 10.1016/j.jvs.2015.07.068

Almasri, 2018, A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia, J Vasc Surg, 68, 624, 10.1016/j.jvs.2018.01.066

Murad, 2017, Clinical practice guidelines: a primer on development and dissemination, Mayo Clin Proc, 92, 423, 10.1016/j.mayocp.2017.01.001

Guyatt, 2016, Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group, J Clin Epidemiol, 80, 3, 10.1016/j.jclinepi.2016.07.006

Mills, 2014, The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI), J Vasc Surg, 59, 220, 10.1016/j.jvs.2013.08.003

Jaff, 2015, Catheter Cardiovasc Interv, 86, 611, 10.1002/ccd.26122

Bollinger, 1981, Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images, Atherosclerosis, 38, 339, 10.1016/0021-9150(81)90050-2

Menard, 2016, Design and rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) trial, J Am Heart Assoc, 5, e003219, 10.1161/JAHA.116.003219

Popplewell, 2016, Bypass versus angioplasty in severe ischaemia of the leg-2 (BASIL-2) trial: study protocol for a randomised controlled trial, Trials, 17, 11, 10.1186/s13063-015-1114-2

Hunt, 2017, BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial, Trials, 18, 224, 10.1186/s13063-017-1968-6

de Graaff, 2003, Evaluation of toe pressure and transcutaneous oxygen measurements in management of chronic critical leg ischemia: a diagnostic randomized clinical trial, J Vasc Surg, 38, 528, 10.1016/S0741-5214(03)00414-2

Brownrigg, 2016, Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review, Diabetes Metab Res Rev, 32, 128, 10.1002/dmrr.2704

Wang, 2016, A systematic review and meta-analysis of tests to predict wound healing in diabetic foot, J Vasc Surg, 63, 29S, 10.1016/j.jvs.2015.10.004

Lijmer, 1996, ROC analysis of noninvasive tests for peripheral arterial disease, Ultrasound Med Biol, 22, 391, 10.1016/0301-5629(96)00036-1

Dachun, 2010, Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review, Vasc Med, 15, 361, 10.1177/1358863X10378376

Aboyans, 2008, The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects, J Vasc Surg, 48, 1197, 10.1016/j.jvs.2008.06.005

Salaun, 2018, Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort, Angiology

Shirasu, 2016, Pulse volume recordings to identify falsely elevated ankle brachial index, Asian Cardiovasc Thorac Ann, 24, 517, 10.1177/0218492316651527

Hingorani, 2008, Limitations of and lessons learned from clinical experience of 1,020 duplex arteriography, Vascular, 16, 147, 10.2310/6670.2008.00014

Larch, 1997, Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography, J Vasc Surg, 25, 629, 10.1016/S0741-5214(97)70288-X

Adriaensen, 2004, Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations, Radiology, 233, 385, 10.1148/radiol.2331031595

Hingorani, 2004, A comparison of magnetic resonance angiography, contrast arteriography, and duplex arteriography for patients undergoing lower extremity revascularization, Ann Vasc Surg, 18, 294, 10.1007/s10016-004-0039-0

Collins, 2007, A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease, Health Technol Assess, 11, 10.3310/hta11200

Met, 2009, Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis, JAMA, 301, 415, 10.1001/jama.301.4.415

1997, Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities, Eur J Vasc Endovasc Surg, 14, 91

Armstrong, 2014, Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease, J Vasc Surg, 60, 1565, 10.1016/j.jvs.2014.08.064

Faglia, 2014, Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study, Diabetes Res Clin Pract, 103, 292, 10.1016/j.diabres.2013.12.060

2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71

Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1

1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3

Hiatt, 2017, Ticagrelor versus clopidogrel in symptomatic peripheral artery disease, N Engl J Med, 376, 32, 10.1056/NEJMoa1611688

Anand, 2018, Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial, Lancet, 391, 219, 10.1016/S0140-6736(17)32409-1

Anand, 2007, Oral anticoagulant and antiplatelet therapy and peripheral arterial disease, N Engl J Med, 357, 217, 10.1056/NEJMoa065959

Leng, 2000, Lipid-lowering for lower limb atherosclerosis, Cochrane Database Syst Rev, 2, CD000123

2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3

Meade, 2002, Bezafibrate in men with lower extremity arterial disease: randomised controlled trial, BMJ, 325, 1139, 10.1136/bmj.325.7373.1139

Aung, 2007, Lipid-lowering for peripheral arterial disease of the lower limb, Cochrane Database Syst Rev, 4, CD000123

Mills, 2011, Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients, Eur Heart J, 32, 1409, 10.1093/eurheartj/ehr035

Rodriguez, 2017, Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease, JAMA Cardiol, 2, 47, 10.1001/jamacardio.2016.4052

Cushman, 2010, Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med, 362, 1575, 10.1056/NEJMoa1001286

Bavry, 2010, Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy, Hypertension, 55, 48, 10.1161/HYPERTENSIONAHA.109.142240

Wright, 2015, A randomized trial of intensive versus standard blood-pressure control, N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939

Moise, 2016, Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: the Cardiovascular Disease Policy Model, Hypertension, 68, 88, 10.1161/HYPERTENSIONAHA.115.06814

Selvin, 2004, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus, Ann Intern Med, 141, 421, 10.7326/0003-4819-141-6-200409210-00007

Nathan, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 353, 2643, 10.1056/NEJMoa052187

van Dieren, 2014, Intensification of medication and glycaemic control among patients with type 2 diabetes—the ADVANCE trial, Diabetes Obes Metab, 16, 426, 10.1111/dom.12238

Fox, 2015, Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association, Diabetes Care, 38, 1777, 10.2337/dci15-0012

2018, 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018, Diabetes Care, 41, S55

Palmer, 2016, Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis, JAMA, 316, 313, 10.1001/jama.2016.9400

Nawaz, 1998, Clinical risk associated with contrast angiography in metformin treated patients: a clinical review, Clin Radiol, 53, 342, 10.1016/S0009-9260(98)80005-6

Goergen, 2010, Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin, Radiology, 254, 261, 10.1148/radiol.09090690

Stacul, 2011, Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines, Eur Radiol, 21, 2527, 10.1007/s00330-011-2225-0

Dagenais, 2005, Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial, Eur J Cardiovasc Prev Rehabil, 12, 75, 10.1177/204748730501200112

Athyros, 2013, The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study, Curr Vasc Pharmacol, 11, 779, 10.2174/1570161111311050016

Blomster, 2016, The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial, BMJ Open, 6, e009668, 10.1136/bmjopen-2015-009668

Kondo, 2011, Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers, Circ J, 75, 2885, 10.1253/circj.CJ-11-0416

Newhall, 2017, Impact and duration of brief surgeon-delivered smoking cessation advice on attitudes regarding nicotine dependence and tobacco harms for patients with peripheral arterial disease, Ann Vasc Surg, 38, 113, 10.1016/j.avsg.2016.06.005

Biancari, 2007, Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study, World J Surg, 31, 217, 10.1007/s00268-006-0242-y

Schanzer, 2008, Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data, J Vasc Surg, 48, 1464, 10.1016/j.jvs.2008.07.062

Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making, J Vasc Surg, 51, 52S, 10.1016/j.jvs.2010.01.077

Meltzer, 2013, The Comprehensive Risk Assessment for Bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia, J Vasc Surg, 57, 1186, 10.1016/j.jvs.2012.09.083

Simons, 2016, A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass, J Vasc Surg, 63, 990, 10.1016/j.jvs.2015.09.051

Cull, 2014, An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system, J Vasc Surg, 60, 1535, 10.1016/j.jvs.2014.08.107

Zhan, 2015, The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing, J Vasc Surg, 61, 939, 10.1016/j.jvs.2014.11.045

Causey, 2016, Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program, J Vasc Surg, 63, 1563, 10.1016/j.jvs.2016.01.011

Darling, 2016, Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia, J Vasc Surg, 64, 616, 10.1016/j.jvs.2016.03.417

Robinson, 2017, Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center, J Vasc Surg, 66, 488, 10.1016/j.jvs.2017.01.063

Sheehan, 2003, Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial, Diabetes Care, 26, 1879, 10.2337/diacare.26.6.1879

Cardinal, 2008, Early healing rates and wound area measurements are reliable predictors of later complete wound closure, Wound Repair Regen, 16, 19, 10.1111/j.1524-475X.2007.00328.x

Lavery, 2008, Prediction of healing for postoperative diabetic foot wounds based on early wound area progression, Diabetes Care, 31, 26, 10.2337/dc07-1300

Snyder, 2010, A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks, Ostomy Wound Manage, 56, 44

Seeger, 1987, Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery, Ann Surg, 205, 733, 10.1097/00000658-198706000-00016

Wengerter, 1990, Influence of vein size (diameter) on infrapopliteal reversed vein graft patency, J Vasc Surg, 11, 525, 10.1016/0741-5214(90)90297-N

Schanzer, 2007, Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial, J Vasc Surg, 46, 1180, 10.1016/j.jvs.2007.08.033

Harward, 1995, Limb-threatening ischemia due to multilevel arterial occlusive disease. Simultaneous or staged inflow/outflow revascularization, Ann Surg, 221, 498, 10.1097/00000658-199505000-00007

Zukauskas, 1995, Sequential aortofemoropopliteal/distal bypass for treatment of critical lower-limb ischaemia, Cardiovasc Surg, 3, 671, 10.1016/0967-2109(96)82868-7

Jongkind, 2010, A systematic review of endovascular treatment of extensive aortoiliac occlusive disease, J Vasc Surg, 52, 1376, 10.1016/j.jvs.2010.04.080

Ye, 2011, Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions, J Vasc Surg, 53, 1728, 10.1016/j.jvs.2011.02.005

Deloose, 2017, Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results, J Cardiovasc Surg (Torino), 58, 416

Ricco, 2008, Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease, J Vasc Surg, 47, 45, 10.1016/j.jvs.2007.08.050

Chiu, 2010, Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease, Eur J Vasc Endovasc Surg, 39, 460, 10.1016/j.ejvs.2009.12.014

Indes, 2013, Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis, J Endovasc Ther, 20, 443, 10.1583/13-4242.1

Kang, 2008, Common femoral artery occlusive disease: contemporary results following surgical endarterectomy, J Vasc Surg, 48, 872, 10.1016/j.jvs.2008.05.025

Ballotta, 2010, Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study, Surgery, 147, 268, 10.1016/j.surg.2009.08.004

Chang, 2008, Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease, J Vasc Surg, 48, 362, 10.1016/j.jvs.2008.03.042

Baumann, 2011, Endovascular treatment of common femoral artery obstructions, J Vasc Surg, 53, 1000, 10.1016/j.jvs.2010.10.076

Bonvini, 2011, Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures, J Am Coll Cardiol, 58, 792, 10.1016/j.jacc.2011.01.070

Gouëffic, 2017, Stenting or surgery for de novo common femoral artery stenosis, JACC Cardiovasc Interv, 10, 1344, 10.1016/j.jcin.2017.03.046

Siracuse, 2017, Endovascular treatment of the common femoral artery in the Vascular Quality Initiative, J Vasc Surg, 65, 1039, 10.1016/j.jvs.2016.10.078

Azuma, 2012, Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?, Eur J Vasc Endovasc Surg, 43, 322, 10.1016/j.ejvs.2011.12.001

Sumpio, 2013, Clinical implications of the angiosome model in peripheral vascular disease, J Vasc Surg, 58, 814, 10.1016/j.jvs.2013.06.056

Biancari, 2014, Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis, Eur J Vasc Endovasc Surg, 47, 517, 10.1016/j.ejvs.2013.12.010

Chae, 2016, Is angiosome-targeted angioplasty effective for limb salvage and wound healing in diabetic foot? A meta-analysis, PLoS One, 11, e0159523, 10.1371/journal.pone.0159523

Jongsma, 2017, Angiosome-directed revascularization in patients with critical limb ischemia, J Vasc Surg, 65, 1208, 10.1016/j.jvs.2016.10.100

Schillinger, 2006, Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Engl J Med, 354, 1879, 10.1056/NEJMoa051303

Saxon, 2008, Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease, J Vasc Interv Radiol, 19, 823, 10.1016/j.jvir.2008.02.008

Dake, 2011, Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results, Circ Cardiovasc Interv, 4, 495, 10.1161/CIRCINTERVENTIONS.111.962324

Rosenfield, 2015, Trial of a paclitaxel-coated balloon for femoropopliteal artery disease, N Engl J Med, 373, 145, 10.1056/NEJMoa1406235

Mills, 1992, Contribution of routine intraoperative completion arteriography to early infrainguinal bypass patency, Am J Surg, 164, 506, 10.1016/S0002-9610(05)81190-0

Bandyk, 1994, Intraoperative duplex scanning of arterial reconstructions: fate of repaired and unrepaired defects, J Vasc Surg, 20, 426, 10.1016/0741-5214(94)90142-2

Ubbink, 2013, Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia, Cochrane Database Syst Rev, 2, CD004001

Karanth, 2016, Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease, Cochrane Database Syst Rev, 12, CD011519

Vietto, 2018, Prostanoids for critical limb ischaemia, Cochrane Database Syst Rev, 1, CD006544

Smith, 2012, Intravenous naftidrofuryl for critical limb ischaemia, Cochrane Database Syst Rev, 7, CD002070

Kranke, 2015, Hyperbaric oxygen therapy for chronic wounds, Cochrane Database Syst Rev, 6, CD004123

Game, 2016, Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review, Diabetes Metab Res Rev, 32, 154, 10.1002/dmrr.2707

Santema, 2018, Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial, Diabetes Care, 41, 112, 10.2337/dc17-0654

Peeters Weem, 2015, Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials, Eur J Vasc Endovasc Surg, 50, 775, 10.1016/j.ejvs.2015.08.018

Elsherif, 2018, Quality of time spent without symptoms of disease or toxicity of treatment for transmetatarsal amputation versus digital amputation in diabetic patients with digital gangrene, Vascular, 26, 142, 10.1177/1708538117718108

Aziz, 2015, The influence of do-not-resuscitate status on the outcomes of patients undergoing emergency vascular operations, J Vasc Surg, 61, 1538, 10.1016/j.jvs.2014.11.087

Siracuse, 2015, Impact of "do not resuscitate" status on the outcome of major vascular surgical procedures, Ann Vasc Surg, 29, 1339, 10.1016/j.avsg.2015.05.014

Reed, 2008, Major lower extremity amputation after multiple revascularizations: was it worth it?, Ann Vasc Surg, 22, 335, 10.1016/j.avsg.2007.07.039

Rollins, 1985, Isolated profundaplasty for limb salvage, J Vasc Surg, 2, 585, 10.1016/0741-5214(85)90014-X

Miksic, 1986, Profunda femoris revascularization in limb salvage, J Cardiovasc Surg (Torino), 27, 544

Ayoub, 1993, Thru-knee amputation: the operation of choice for non-ambulatory patients, Am Surg, 59, 619

Taylor, 2008, "Successful outcome" after below-knee amputation: an objective definition and influence of clinical variables, Am Surg, 74, 607, 10.1177/000313480807400707

Webster, 2012, Prosthetic fitting, use, and satisfaction following lower-limb amputation: a prospective study, J Rehabil Res Dev, 49, 1493, 10.1682/JRRD.2012.01.0001

Bradley, 2006, Secondary prevention of arteriosclerosis in lower limb vascular amputees: a missed opportunity, Eur J Vasc Endovasc Surg, 32, 491, 10.1016/j.ejvs.2006.07.005

Glaser, 2013, Fate of the contralateral limb after lower extremity amputation, J Vasc Surg, 58, 1571, 10.1016/j.jvs.2013.06.055

Abbruzzese, 2004, Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts, J Vasc Surg, 39, 1178, 10.1016/j.jvs.2003.12.027

Henke, 2004, Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality, J Vasc Surg, 39, 357, 10.1016/j.jvs.2003.08.030

Brown, 2008, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, 4, CD000535

Bedenis, 2015, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, 2, CD000535

Suckow, 2015, Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival, J Vasc Surg, 61, 126, 10.1016/j.jvs.2014.05.093

Hobbs, 2003, Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach, Eur J Vasc Endovasc Surg, 26, 341, 10.1016/S1078-5884(03)00356-3

Willigendael, 2005, Smoking and the patency of lower extremity bypass grafts: a meta-analysis, J Vasc Surg, 42, 67, 10.1016/j.jvs.2005.03.024

Belch, 2010, Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial, J Vasc Surg, 52, 825, 10.1016/j.jvs.2010.04.027

Gassman, 2014, Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency, Vascular, 22, 105, 10.1177/1708538112473977

Cassar, 2005, Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty, Br J Surg, 92, 159, 10.1002/bjs.4810

Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989

Tepe, 2012, Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial, Eur Radiol, 22, 1998, 10.1007/s00330-012-2441-2

Strobl, 2013, Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease, J Endovasc Ther, 20, 699, 10.1583/13-4275MR.1

Mills, 2001, The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair, J Vasc Surg, 33, 273, 10.1067/mva.2001.112701

Landry, 2002, Long-term outcome of revised lower-extremity bypass grafts, J Vasc Surg, 35, 56

Nguyen, 2004, Infrainguinal vein bypass graft revision: factors affecting long-term outcome, J Vasc Surg, 40, 916, 10.1016/j.jvs.2004.08.038

Bui, 2012, The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance, J Vasc Surg, 55, 346, 10.1016/j.jvs.2011.08.010

Humphries, 2011, Early duplex scanning after infrainguinal endovascular therapy, J Vasc Surg, 53, 353, 10.1016/j.jvs.2010.08.045

Elraiyah, 2016, A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers, J Vasc Surg, 63, 59S, 10.1016/j.jvs.2015.10.006

Bell, 1982, The definition of critical ischaemia of a limb, Br J Surg, 69, S2

Thompson, 1993, Chronic critical leg ischaemia must be redefined, Eur J Vasc Surg, 7, 420, 10.1016/S0950-821X(05)80260-9

Hafner, 2000, Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia, J Am Acad Dermatol, 43, 1001, 10.1067/mjd.2000.108375

Fontaine, 1954, [Surgical treatment of peripheral circulation disorders], Helv Chir Acta, 21, 499

Meggitt, 1976, Surgical management of the diabetic foot, Br J Hosp Med, 16, 227

Wagner, 1981, The dysvascular foot: a system for diagnosis and treatment, Foot Ankle, 2, 64, 10.1177/107110078100200202

1991, Second European Consensus Document on chronic critical leg ischemia, Circulation, 84, IV1

Rutherford, 1997, Recommended standards for reports dealing with lower extremity ischemia: revised version, J Vasc Surg, 26, 517, 10.1016/S0741-5214(97)70045-4

Armstrong, 1998, Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation, Diabetes Care, 21, 855, 10.2337/diacare.21.5.855

Macfarlane, 1999, Classification of diabetic foot ulcers: the S(AD) SAD system, Diabetic Foot, 2, 123

Dormandy, 2000, Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC), J Vasc Surg, 31, S1

Schaper, 2004, Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies, Diabetes Metab Res Rev, 20, S90, 10.1002/dmrr.464

Norgren, 2007, Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), J Vasc Surg, 45, S5, 10.1016/j.jvs.2006.12.037

Martinez-De Jesus, 2010, A checklist system to score healing progress of diabetic foot ulcers, Int J Low Extrem Wounds, 9, 74, 10.1177/1534734610371594

Lipsky, 2012, 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections, Clin Infect Dis, 54, e132, 10.1093/cid/cis346

Adam, 2005, Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet, 366, 1925, 10.1016/S0140-6736(05)67704-5

Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received, J Vasc Surg, 51, 18S, 10.1016/j.jvs.2010.01.074

Shishehbor, 2016, An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines-recommended hemodynamic parameters to diagnose critical limb ischemia, J Vasc Surg, 63, 1311, 10.1016/j.jvs.2015.11.042

Conte, 2009, Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia, J Vasc Surg, 50, 1462, 10.1016/j.jvs.2009.09.044

Beropoulis, 2016, Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia, J Vasc Surg, 64, 95, 10.1016/j.jvs.2016.01.040

Darling, 2017, Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations, J Vasc Surg, 65, 695, 10.1016/j.jvs.2016.09.055

Mathioudakis, 2017, The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system predicts wound healing but not major amputation in patients with diabetic foot ulcers treated in a multidisciplinary setting, J Vasc Surg, 65, 1698, 10.1016/j.jvs.2016.12.123

Ward, 2017, Outcomes of critical limb ischemia in an urban, safety net hospital population with high WIfI amputation scores, Ann Vasc Surg, 38, 84, 10.1016/j.avsg.2016.08.005

Tokuda, 2018, Use of the Wound, Ischemia, foot Infection classification system in hemodialysis patients after endovascular treatment for critical limb ischemia, J Vasc Surg, 67, 1762, 10.1016/j.jvs.2017.09.037

White, 2007, Chronic subcritical limb ischemia: a poorly recognized stage of critical limb ischemia, Semin Vasc Surg, 20, 62, 10.1053/j.semvascsurg.2007.02.001

Salaun, 2018, Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort, Angiology

Graziani, 2007, Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity, Eur J Vasc Endovasc Surg, 33, 453, 10.1016/j.ejvs.2006.11.022

Ramanan, 2017, Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program, J Vasc Surg, 66, 1765, 10.1016/j.jvs.2017.05.102

Kobayashi, 2018, Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia, Catheter Cardiovasc Interv, 91, 505, 10.1002/ccd.27238

Leithead, 2018, Importance of postprocedural Wound, Ischemia, and foot Infection (WIfI) restaging in predicting limb salvage, J Vasc Surg, 67, 498, 10.1016/j.jvs.2017.07.109

Hirsch, 2012, A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association, Circulation, 125, 1449, 10.1161/CIR.0b013e31824c39ba

Marrett, 2013, Burden of peripheral arterial disease in Europe and the United States: a patient survey, Health Qual Life Outcomes, 11, 175, 10.1186/1477-7525-11-175

Howard, 2015, Population-based study of incidence, risk factors, outcome, and prognosis of ischemic peripheral arterial events: implications for prevention, Circulation, 132, 1805, 10.1161/CIRCULATIONAHA.115.016424

Olinic, 2018, Epidemiology of peripheral artery disease in Europe: VAS Educational Paper, Int Angiol, 37, 327, 10.23736/S0392-9590.18.03996-2

Kojima, 2014, A low ankle brachial index is associated with an increased risk of cardiovascular disease: the Hisayama study, J Atheroscler Thromb, 21, 966, 10.5551/jat.22608

Sheng, 2016, Pulse waves in the lower extremities as a diagnostic tool of peripheral arterial disease and predictor of mortality in elderly Chinese, Hypertension, 67, 527, 10.1161/HYPERTENSIONAHA.115.06666

Desormais, 2014, Prevalence of peripheral artery disease in the elderly population in urban and rural areas of Central Africa: the EPIDEMCA study, Eur J Prev Cardiol, 22, 1462, 10.1177/2047487314557945

Newman, 1993, Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group, Circulation, 88, 837, 10.1161/01.CIR.88.3.837

Criqui, 2010, The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 56, 1506, 10.1016/j.jacc.2010.04.060

Guerchet, 2012, Epidemiology of peripheral artery disease in elder general population of two cities of Central Africa: Bangui and Brazzaville, Eur J Vasc Endovasc Surg, 44, 164, 10.1016/j.ejvs.2012.05.019

Forbang, 2014, Peripheral artery disease and non-coronary atherosclerosis in Hispanics: another paradox?, Prog Cardiovasc Dis, 57, 237, 10.1016/j.pcad.2014.07.008

Aboyans, 2007, Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA), J Vasc Surg, 45, 319, 10.1016/j.jvs.2006.10.032

Criqui, 2015, Epidemiology of peripheral artery disease, Circ Res, 116, 1509, 10.1161/CIRCRESAHA.116.303849

Nehler, 2014, Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population, J Vasc Surg, 60, 686, 10.1016/j.jvs.2014.03.290

Criqui, 1985, The prevalence of peripheral arterial disease in a defined population, Circulation, 71, 510, 10.1161/01.CIR.71.3.510

Gallotta, 1997, Prevalence of peripheral arterial disease in an elderly rural population of southern Italy, Gerontology, 43, 289, 10.1159/000213865

Sigvant, 2011, Differences in presentation of symptoms between women and men with intermittent claudication, BMC Cardiovasc Disord, 11, 39, 10.1186/1471-2261-11-39

Moss, 1999, The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, Diabetes Care, 22, 951, 10.2337/diacare.22.6.951

Prompers, 2008, Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study, Diabetologia, 51, 747, 10.1007/s00125-008-0940-0

Ix, 2011, Association of body mass index with peripheral arterial disease in older adults: the Cardiovascular Health Study, Am J Epidemiol, 174, 1036, 10.1093/aje/kwr228

Martinez-Aguilar, 2017, Reduced high-density lipoprotein cholesterol: a valuable, independent prognostic marker in peripheral arterial disease, J Vasc Surg, 66, 1527, 10.1016/j.jvs.2017.04.056

Ridker, 2001, Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease, JAMA, 285, 2481, 10.1001/jama.285.19.2481

Peng, 2017, Hypertriglyceridemia and atherosclerosis, Lipids Health Dis, 16, 233, 10.1186/s12944-017-0625-0

Vliegenthart, 2002, Alcohol consumption and risk of peripheral arterial disease: the Rotterdam study, Am J Epidemiol, 155, 332, 10.1093/aje/155.4.332

Kaufman, 2016, Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study, Lancet, 388, 696, 10.1016/S0140-6736(16)00378-0

Khandanpour, 2009, Homocysteine and peripheral arterial disease: systematic review and meta-analysis, Eur J Vasc Endovasc Surg, 38, 316, 10.1016/j.ejvs.2009.05.007

Prushik, 2012, Parental intermittent claudication as risk factor for claudication in adults, Am J Cardiol, 109, 736, 10.1016/j.amjcard.2011.10.032

Wassel, 2012, Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium, Atherosclerosis, 222, 138, 10.1016/j.atherosclerosis.2012.01.039

Fowkes, 1991, Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population, Int J Epidemiol, 20, 384, 10.1093/ije/20.2.384

Batty, 2014, Psychological distress and risk of peripheral vascular disease, abdominal aortic aneurysm, and heart failure: pooling of sixteen cohort studies, Atherosclerosis, 236, 385, 10.1016/j.atherosclerosis.2014.06.025

Prompers, 2007, High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study, Diabetologia, 50, 18, 10.1007/s00125-006-0491-1

Norgren, 2007, Inter-society consensus for the management of peripheral arterial disease, Int Angiol, 26, 81

Biancari, 2013, Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia, J Cardiovasc Surg (Torino), 54, 663

Ziegler-Graham, 2008, Estimating the prevalence of limb loss in the United States: 2005 to 2050, Arch Phys Med Rehabil, 89, 422, 10.1016/j.apmr.2007.11.005

Peacock, 2011, The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008, Prev Chronic Dis, 8, A141

Moxey, 2011, Lower extremity amputations—a review of global variability in incidence, Diabet Med, 28, 1144, 10.1111/j.1464-5491.2011.03279.x

Vamos, 2010, Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008, Diabetes Care, 33, 2592, 10.2337/dc10-0989

Lombardo, 2014, Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010, PLoS One, 9, e86405, 10.1371/journal.pone.0086405

Hirsch, 2006, J Am Coll Cardiol, 47, 1239, 10.1016/j.jacc.2005.10.009

Sigvant, 2016, The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease, Eur J Vasc Endovasc Surg, 51, 395, 10.1016/j.ejvs.2015.10.022

Nehler, 2003, Is revascularization and limb salvage always the best treatment for critical limb ischemia?, J Vasc Surg, 37, 704, 10.1067/mva.2003.142

Nehler, 2003, Functional outcomes and quality of life in peripheral arterial disease: current status, Vasc Med, 8, 115, 10.1191/1358863x03vm483ra

Reinecke, 2015, Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence, Eur Heart J, 36, 932, 10.1093/eurheartj/ehv006

Behrendt, 2018, International variations in amputation practice: a VASCUNET report, Eur J Vasc Endovasc Surg, 56, 391, 10.1016/j.ejvs.2018.04.017

van Haelst, 2018, Cardiovascular and all-cause mortality in patients with intermittent claudication and critical limb ischaemia, Br J Surg, 105, 252, 10.1002/bjs.10657

Baubeta Fridh, 2017, Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study, Eur J Vasc Endovasc Surg, 54, 480, 10.1016/j.ejvs.2017.07.005

Ortmann, 2012, Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemia, J Vasc Surg, 55, 98, 10.1016/j.jvs.2011.07.074

Hobbs, 2003, Ethnicity and peripheral arterial disease, Eur J Vasc Endovasc Surg, 25, 505, 10.1053/ejvs.2002.1884

Diehm, 2006, Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty, Eur J Vasc Endovasc Surg, 31, 59, 10.1016/j.ejvs.2005.09.006

Armstrong, 2014, Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease, J Am Heart Assoc, 3, e000697, 10.1161/JAHA.113.000697

Soga, 2014, Two-year life expectancy in patients with critical limb ischemia, JACC Cardiovasc Interv, 7, 1444, 10.1016/j.jcin.2014.06.018

Sampson, 2014, Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010, Glob Heart, 9, 145, 10.1016/j.gheart.2013.12.008

Cull, 2010, Open versus endovascular intervention for critical limb ischemia: a population-based study, J Am Coll Surg, 210, 555, 10.1016/j.jamcollsurg.2009.12.019

Moxey, 2010, Epidemiological study of lower limb amputation in England between 2003 and 2008, Br J Surg, 97, 1348, 10.1002/bjs.7092

2015, Summary of the proceedings of the International Summit 2015: general and subspecialty radiology, Insights Imaging, 7, 1

Wolfe, 1997, Critical and subcritical ischaemia, Eur J Vasc Endovasc Surg, 13, 578, 10.1016/S1078-5884(97)80067-6

Conde, 2014, Evaluation of the patient who presents with critical limb ischemia: diagnosis, prognosis, and medical management, Tech Vasc Interv Radiol, 17, 140, 10.1053/j.tvir.2014.08.002

Morgan, 2001, Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia, J Vasc Surg, 33, 679, 10.1067/mva.2001.112326

Nguyen, 2006, Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia, J Vasc Surg, 44, 977, 10.1016/j.jvs.2006.07.015

Gerhard-Herman, 2017, 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 135, e726

Aboyans, 2018, Editor's choice—2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS), Eur J Vasc Endovasc Surg, 55, 305, 10.1016/j.ejvs.2017.07.018

Criqui, 1985, The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population, Circulation, 71, 516, 10.1161/01.CIR.71.3.516

Feigelson, 1994, Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population, Am J Epidemiol, 140, 526, 10.1093/oxfordjournals.aje.a117279

McGee, 1998, Physical examination and chronic lower-extremity ischemia: a critical review, Arch Intern Med, 158, 1357, 10.1001/archinte.158.12.1357

Khan, 2006, Does the clinical examination predict lower extremity peripheral arterial disease?, JAMA, 295, 536, 10.1001/jama.295.5.536

Cournot, 2007, Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects, J Vasc Surg, 46, 1215, 10.1016/j.jvs.2007.08.022

Armstrong, 1998, Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration, Arch Intern Med, 158, 289, 10.1001/archinte.158.3.289

Kamei, 2005, Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening, J Diabetes Complications, 19, 47, 10.1016/j.jdiacomp.2003.12.006

Feng, 2009, The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy, J Vasc Surg, 50, 675, 10.1016/j.jvs.2009.05.017

O'Brien, 2014, An initial evaluation of a proof-of-concept 128-Hz electronic tuning fork in the detection of peripheral neuropathy, J Am Podiatr Med Assoc, 104, 134, 10.7547/0003-0538-104.2.134

Lam, 2016, Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review, Clin Infect Dis, 63, 944, 10.1093/cid/ciw445

Schaper, 2017, Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents, Diabetes Res Clin Pract, 124, 84, 10.1016/j.diabres.2016.12.007

Hirsch, 2006, Circulation, 113, e463, 10.1161/CIRCULATIONAHA.106.174526

Al-Qaisi, 2009, Ankle brachial pressure index (ABPI): an update for practitioners, Vasc Health Risk Manag, 5, 833, 10.2147/VHRM.S6759

Gornik, 2009, Rethinking the morbidity of peripheral arterial disease and the "normal" ankle-brachial index, J Am Coll Cardiol, 53, 1063, 10.1016/j.jacc.2008.12.019

Silvestro, 2006, Falsely high ankle-brachial index predicts major amputation in critical limb ischemia, Vasc Med, 11, 69, 10.1191/1358863x06vm678oa

Aboyans, 2012, Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association, Circulation, 126, 2890, 10.1161/CIR.0b013e318276fbcb

Tyrrell, 1993, Critical leg ischaemia: an appraisal of clinical definitions. Joint Vascular Research Group, Br J Surg, 80, 177

Castronuovo, 1997, Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia, J Vasc Surg, 26, 629, 10.1016/S0741-5214(97)70062-4

Abbas, 2008, Comparison of four systems of classification of diabetic foot ulcers in Tanzania, Diabet Med, 25, 134, 10.1111/j.1464-5491.2007.02308.x

Parisi, 2008, Comparison of three systems of classification in predicting the outcome of diabetic foot ulcers in a Brazilian population, Eur J Endocrinol, 159, 417, 10.1530/EJE-07-0841

Santema, 2016, Comparing the Meggitt-Wagner and the University of Texas wound classification systems for diabetic foot ulcers: inter-observer analyses, Int Wound J, 13, 1137, 10.1111/iwj.12429

Swanberg, 2014, Selective intra-arterial dual-energy CT angiography (s-CTA) in lower extremity arterial occlusive disease, Eur J Vasc Endovasc Surg, 48, 325, 10.1016/j.ejvs.2014.05.013

Moneta, 1993, Noninvasive localization of arterial occlusive disease: a comparison of segmental Doppler pressures and arterial duplex mapping, J Vasc Surg, 17, 578, 10.1016/0741-5214(93)90158-I

Pinto, 1996, Peripheral ischemic occlusive arterial disease: comparison of color Doppler sonography and angiography, J Ultrasound Med, 15, 697, 10.7863/jum.1996.15.10.697

Hou, 2018, Prospects of contrast-enhanced ultrasonography for the diagnosis of peripheral arterial disease: a meta-analysis, J Ultrasound Med, 37, 1081, 10.1002/jum.14451

Ligush, 1998, Duplex ultrasound scanning defines operative strategies for patients with limb-threatening ischemia, J Vasc Surg, 28, 482, 10.1016/S0741-5214(98)70134-X

Proia, 2001, Early results of infragenicular revascularization based solely on duplex arteriography, J Vasc Surg, 33, 1165, 10.1067/mva.2001.115376

Ota, 2004, MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images, AJR Am J Roentgenol, 182, 201, 10.2214/ajr.182.1.1820201

Romano, 2004, Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement, Eur J Radiol, 50, 303, 10.1016/S0720-048X(03)00118-9

Edwards, 2005, Multidetector row CT angiography of the lower limb arteries: a prospective comparison of volume-rendered techniques and intra-arterial digital subtraction angiography, Clin Radiol, 60, 85, 10.1016/j.crad.2004.07.011

Heijenbrok-Kal, 2007, Lower extremity arterial disease: multidetector CT angiography meta-analysis, Radiology, 245, 433, 10.1148/radiol.2451061280

Thomsen, 2006, ESUR guidelines on contrast media, Abdom Imaging, 31, 131, 10.1007/s00261-005-0380-y

Smith-Bindman, 2009, Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer, Arch Intern Med, 169, 2078, 10.1001/archinternmed.2009.427

Solomon, 2005, The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients, Kidney Int, 68, 2256, 10.1111/j.1523-1755.2005.00684.x

van der Molen, 2018, Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR Contrast Medium Safety Committee guidelines, Eur Radiol, 28, 2856, 10.1007/s00330-017-5247-4

Spinazzi, 2004, [Administration of iodinated contrast in patients with pre-existing renal failure: a review], Radiol Med, 107, 88

Carpenter, 1994, Peripheral vascular surgery with magnetic resonance angiography as the sole preoperative imaging modality, J Vasc Surg, 20, 861, 10.1016/0741-5214(94)90222-4

Mell, 2007, Clinical utility of time-resolved imaging of contrast kinetics (TRICKS) magnetic resonance angiography for infrageniculate arterial occlusive disease, J Vasc Surg, 45, 543, 10.1016/j.jvs.2006.11.045

Kreitner, 2008, MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA, J Magn Reson Imaging, 27, 78, 10.1002/jmri.21226

Menke, 2010, Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease, Ann Intern Med, 153, 325, 10.7326/0003-4819-153-5-201009070-00007

Altaha, 2017, Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS) and TSE-based subtraction techniques, Eur Radiol, 27, 1218, 10.1007/s00330-016-4448-6

Kribben, 2009, Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy, J Am Coll Cardiol, 53, 1621, 10.1016/j.jacc.2008.12.061

Turowski, 2015, An appeal to standardize CT- and MR-perfusion, Clin Neuroradiol, 25, 205, 10.1007/s00062-015-0444-5

Grözinger, 2014, Perfusion measurements of the calf in patients with peripheral arterial occlusive disease before and after percutaneous transluminal angioplasty using MR arterial spin labeling, J Magn Reson Imaging, 40, 980, 10.1002/jmri.24463

Hingorani, 2004, Magnetic resonance angiography versus duplex arteriography in patients undergoing lower extremity revascularization: which is the best replacement for contrast arteriography?, J Vasc Surg, 39, 717, 10.1016/j.jvs.2003.12.035

Lapeyre, 2005, Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography, AJR Am J Roentgenol, 185, 1641, 10.2214/AJR.04.1111

Hessel, 1981, Complications of angiography, Radiology, 138, 273, 10.1148/radiology.138.2.7455105

Aspelin, 2003, Nephrotoxic effects in high-risk patients undergoing angiography, N Engl J Med, 348, 491, 10.1056/NEJMoa021833

Baker, 2003, A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study, J Am Coll Cardiol, 41, 2114, 10.1016/S0735-1097(03)00487-X

Waugh, 1992, Arteriographic complications in the DSA era, Radiology, 182, 243, 10.1148/radiology.182.1.1727290

Palena, 2016, Automated carbon dioxide angiography for the evaluation and endovascular treatment of diabetic patients with critical limb ischemia, J Endovasc Ther, 23, 40, 10.1177/1526602815616924

Jens, 2015, Perfusion angiography of the foot in patients with critical limb ischemia: description of the technique, Cardiovasc Intervent Radiol, 38, 201, 10.1007/s00270-014-1036-5

Vierthaler, 2015, Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia, J Vasc Surg, 62, 655, 10.1016/j.jvs.2015.04.391

Marston, 2006, Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization, J Vasc Surg, 44, 108, 10.1016/j.jvs.2006.03.026

Catalano, 2007, Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial, J Intern Med, 261, 276, 10.1111/j.1365-2796.2006.01763.x

Bonaca, 2016, Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease, J Am Coll Cardiol, 67, 2719, 10.1016/j.jacc.2016.03.524

Bonaca, 2016, Peripheral revascularization in patients with peripheral artery disease with vorapaxar: insights from the TRA 2°P-TIMI 50 Trial, JACC Cardiovasc Interv, 9, 2157, 10.1016/j.jcin.2016.07.034

Sharma, 2017, Safety and efficacy of vorapaxar in secondary prevention of atherosclerotic disease: a meta-analysis of randomized control trials, Int J Cardiol, 227, 617, 10.1016/j.ijcard.2016.10.088

Morrow, 2012, Vorapaxar in the secondary prevention of atherothrombotic events, N Engl J Med, 366, 1404, 10.1056/NEJMoa1200933

Bonaca, 2014, New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2°P-TIMI 50 Trial, J Am Coll Cardiol, 64, 2318, 10.1016/j.jacc.2014.07.997

Katsanos, 2015, Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis, PLoS One, 10, e0135692, 10.1371/journal.pone.0135692

Bonaca, 2016, Circulation, 133, 997, 10.1161/CIRCULATIONAHA.115.019355

Whayne, 2012, A review of the role of anticoagulation in the treatment of peripheral arterial disease, Int J Angiol, 21, 187, 10.1055/s-0032-1330232

Fanari, 2017, Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: meta-analysis of randomized controlled trials, Cardiovasc Revasc Med, 18, 10, 10.1016/j.carrev.2016.07.006

Anand, 2018, Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial, J Am Coll Cardiol, 71, 2306, 10.1016/j.jacc.2018.03.008

Capell, 2018, Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD), Am Heart J, 199, 83, 10.1016/j.ahj.2018.01.011

Ross, 1999, Atherosclerosis—an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207

Libby, 2009, Inflammation in atherosclerosis: from pathophysiology to practice, J Am Coll Cardiol, 54, 2129, 10.1016/j.jacc.2009.09.009

Kaptoge, 2010, C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Lancet, 375, 132, 10.1016/S0140-6736(09)61717-7

McDermott, 2005, Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study, Am Heart J, 150, 276, 10.1016/j.ahj.2004.09.032

Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646

Ridker, 2010, Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER), Am J Cardiol, 106, 204, 10.1016/j.amjcard.2010.03.018

Rogers, 2007, A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin, Clin Ther, 29, 242, 10.1016/j.clinthera.2007.02.001

Foley, 2017, High-intensity statin therapy is associated with improved survival in patients with peripheral artery disease, J Am Heart Assoc, 6, e005699, 10.1161/JAHA.117.005699

Arya, 2018, Association of statin dose with amputation and survival in patients with peripheral artery disease, Circulation, 137, 1435, 10.1161/CIRCULATIONAHA.117.032361

Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2889, 10.1016/j.jacc.2013.11.002

Grundy, 2018, 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol

Bonaca, 2018, Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk), Circulation, 137, 338, 10.1161/CIRCULATIONAHA.117.032235

Williamson, 2016, Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial, JAMA, 315, 2673, 10.1001/jama.2016.7050

2002, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA, 288, 2981, 10.1001/jama.288.23.2981

Piller, 2014, Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT, J Gen Intern Med, 29, 1475, 10.1007/s11606-014-2947-1

Kray, 2017, Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization, Vasc Health Risk Manag, 13, 269, 10.2147/VHRM.S137698

Høgh, 2012, Use of angiotensin-converting enzyme inhibitors and cardiovascular outcomes following primary vascular surgery: a nationwide propensity score matched follow-up study, Vasc Endovascular Surg, 46, 515, 10.1177/1538574412455229

Hogh, 2013, Beta-blocker use and clinical outcomes after primary vascular surgery: a nationwide propensity score-matched study, Eur J Vasc Endovasc Surg, 46, 93, 10.1016/j.ejvs.2013.04.006

Attaei, 2017, Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data, Lancet Public Health, 2, e411, 10.1016/S2468-2667(17)30141-X

Paravastu, 2013, Beta blockers for peripheral arterial disease, Cochrane Database Syst Rev, 9, CD005508

Thomas Manapurathe, 2017, Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: a meta-analysis of randomised controlled trials, PLoS One, 12, e0178713, 10.1371/journal.pone.0178713

Britton, 2012, Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study, Vasc Med, 17, 85, 10.1177/1358863X11436195

Joosten, 2012, Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men, JAMA, 308, 1660, 10.1001/jama.2012.13415

Neal, 2017, Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes, N Engl J Med, 377, 644, 10.1056/NEJMoa1611925

Li, 2018, Risks of diabetic foot syndrome and amputation associated with sodium glucose co-transporter 2 inhibitors: A Meta-analysis of Randomized Controlled Trials, Diabetes Metab, 44, 410, 10.1016/j.diabet.2018.02.001

https://www.fda.gov/Drugs/DrugSafety/ucm557507.htm

Potier, 2019, Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use, Diabetologia, 10.1007/s00125-019-4835-z

Home, 2019, Cardiovascular outcome trials of glucose-lowering medications: an update, Diabetologia, 62, 357, 10.1007/s00125-018-4801-1

Baggish, 2017, Cardiovascular toxicity of illicit anabolic-androgenic steroid use, Circulation, 135, 1991, 10.1161/CIRCULATIONAHA.116.026945

Sandfort, 2017, Coronary plaque progression and regression in asymptomatic African American chronic cocaine users with obstructive coronary stenoses: a preliminary study, J Addict Med, 11, 126

Orr, 2014, Efficacy of electronic cigarettes for smoking cessation, Ann Pharmacother, 48, 1502, 10.1177/1060028014547076

Dehghan, 2017, Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study, Lancet, 390, 2050, 10.1016/S0140-6736(17)32252-3

Kok, 2004, Atherosclerosis—epidemiological studies on the health effects of a Mediterranean diet, Eur J Nutr, 43, I/2

Bhupathiraju, 2011, Coronary heart disease prevention: nutrients, foods, and dietary patterns, Clin Chim Acta, 412, 1493, 10.1016/j.cca.2011.04.038

Nosova, 2015, Advancing beyond the "heart-healthy diet" for peripheral arterial disease, J Vasc Surg, 61, 265, 10.1016/j.jvs.2014.10.022

Vincent-Baudry, 2005, The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet, Am J Clin Nutr, 82, 964, 10.1093/ajcn/82.5.964

Miller, 2016, Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study, Lancet Glob Health, 4, e695, 10.1016/S2214-109X(16)30186-3

Lane, 2014, Exercise for intermittent claudication, Cochrane Database Syst Rev, 7, CD000990

Anderson, 2016, Exercise-based cardiac rehabilitation for coronary heart disease, Cochrane Database Syst Rev, 1, CD001800

Shaffer, 2016, Estimating the effect of intravenous acetaminophen for postoperative pain management on length of stay and inpatient hospital costs, Adv Ther, 33, 2211, 10.1007/s12325-016-0438-y

Helander, 2017, Multimodal analgesia, current concepts, and acute pain considerations, Curr Pain Headache Rep, 21, 3, 10.1007/s11916-017-0607-y

Sianos, 2005, The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease, EuroIntervention, 1, 219

Kolh, 2014, Eur J Cardiothorac Surg, 46, 517, 10.1093/ejcts/ezu366

Rocha-Singh, 2014, Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications, Catheter Cardiovasc Interv, 83, E212, 10.1002/ccd.25387

Patel, 2015, Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC), J Am Coll Cardiol, 65, 931, 10.1016/j.jacc.2014.12.036

Davies, 1991, Infrainguinal polytetrafluoroethylene grafts: saved limbs or wasted effort? A report on ten years' experience, Ann Vasc Surg, 5, 519, 10.1007/BF02015275

Donaldson, 1991, Femoral-distal bypass with in situ greater saphenous vein. Long-term results using the Mills valvulotome, Ann Surg, 213, 457, 10.1097/00000658-199105000-00011

O'Riordain, 1992, Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia, Am J Surg, 164, 129, 10.1016/S0002-9610(05)80370-8

Smith, 1993, Adjuvant prostanoid treatment during femorodistal reconstruction, Ann Vasc Surg, 7, 88, 10.1007/BF02042665

Sayers, 1994, The fate of infrainguinal PTFE grafts and an analysis of factors affecting outcome, Eur J Vasc Surg, 8, 607, 10.1016/S0950-821X(05)80599-7

Hearn, 1996, Analysis of autogenous vein femoral-infrapopliteal bypass for limb salvage in the elderly, Cardiovasc Surg, 4, 105, 10.1016/0967-2109(96)83795-1

Panayiotopoulos, 1997, The concept of knee salvage: why does a failed femorocrural/pedal arterial bypass not affect the amputation level?, Eur J Vasc Endovasc Surg, 13, 477, 10.1016/S1078-5884(97)80176-1

Wijesinghe, 1998, Polytetrafluoroethylene (PTFE) femorodistal grafts with a distal vein cuff for critical ischaemia, Eur J Vasc Endovasc Surg, 15, 449, 10.1016/S1078-5884(98)80209-8

Hamsho, 1999, Prospective randomised trial of distal arteriovenous fistula as an adjunct to femoro-infrapopliteal PTFE bypass, Eur J Vasc Endovasc Surg, 17, 197, 10.1053/ejvs.1998.0671

Johnson, 2000, A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study, J Vasc Surg, 32, 268, 10.1067/mva.2000.106944

Ruckert, 2000, Femorodistal PTFE bypass grafting for severe limb ischaemia: results of a prospective clinical study using a new distal anastomotic technique, Eur J Vasc Endovasc Surg, 20, 51, 10.1053/ejvs.2000.1119

Soder, 2000, Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results, J Vasc Interv Radiol, 11, 1021, 10.1016/S1051-0443(07)61332-3

Dorros, 2001, Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up, Circulation, 104, 2057, 10.1161/hc4201.097943

Schneider, 2001, Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene, J Vasc Surg, 33, 955, 10.1067/mva.2001.114210

Klinkert, 2003, Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage, Ann Vasc Surg, 17, 486, 10.1007/s10016-003-0036-8

Hynes, 2004, Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease, J Endovasc Ther, 11, 460, 10.1583/04-1242.1

Pedersen, 2005, The impact of patient characteristics on long-term results of above-knee prosthetic femoropopliteal bypass for critical ischemia, Int Angiol, 24, 349

Surowiec, 2005, Percutaneous angioplasty and stenting of the superficial femoral artery, J Vasc Surg, 41, 269, 10.1016/j.jvs.2004.11.031

Ascher, 2006, Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases, J Vasc Surg, 44, 1230, 10.1016/j.jvs.2006.08.025

Bosiers, 2006, Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures, Vascular, 14, 63, 10.2310/6670.2006.00014

Peeters, 2006, Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses, J Cardiovasc Surg (Torino), 47, 407

DeRubertis, 2007, Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention, J Vasc Surg, 46, 709, 10.1016/j.jvs.2007.05.059

Jensen, 2007, Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomised study, Eur J Vasc Endovasc Surg, 34, 44, 10.1016/j.ejvs.2007.01.016

Bosiers, 2008, Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent, EuroIntervention, 3, 470, 10.4244/EIJV3I4A84

Dosluoglu, 2008, Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease, J Vasc Surg, 48, 1166, 10.1016/j.jvs.2008.06.006

Giles, 2008, Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs, J Vasc Surg, 48, 128, 10.1016/j.jvs.2008.02.027

Peeters, 2008, Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass?, Ital J Vasc Endovasc Surg, 15, 143

Peregrin, 2008, Self-expandable stent placement in infrapopliteal arteries after unsuccessful angioplasty failure: one-year follow-up, Cardiovasc Intervent Radiol, 31, 860, 10.1007/s00270-007-9292-2

Ah Chong, 2009, Bypass surgery or percutaneous transluminal angioplasty to treat critical lower limb ischaemia due to infrainguinal arterial occlusive disease?, Hong Kong Med J, 15, 249

Deloose, 2009, One year outcome after primary stenting of infrapopliteal lesions with the Chromis Deep stent in the management of critical limb ischaemia, EuroIntervention, 5, 318, 10.4244/V5I3A50

Randon, 2009, Long-term results of femorodistal reconstructions with cryopreserved saphenous vein allografts, Interact Cardiovasc Thorac Surg, 8, S27

Setacci, 2009, Subintimal angioplasty with the aid of a re-entry device for TASC C and D lesions of the SFA, Eur J Vasc Endovasc Surg, 38, 76, 10.1016/j.ejvs.2009.03.020

Siablis, 2009, Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome, J Vasc Interv Radiol, 20, 1141, 10.1016/j.jvir.2009.05.031

Rastan, 2010, Primary use of sirolimus-eluting stents in the infrapopliteal arteries, J Endovasc Ther, 17, 480, 10.1583/10-3073.1

Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy, J Vasc Surg, 51, 5S, 10.1016/j.jvs.2010.01.073

Feiring, 2010, Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial, J Am Coll Cardiol, 55, 1580, 10.1016/j.jacc.2009.11.072

Fransson, 2010, In situ saphenous vein bypass grafting—still first line treatment? A prospective study comparing surgical results between diabetic and non-diabetic populations, Vasa, 39, 59, 10.1024/0301-1526/a000006

Schmidt, 2010, Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease, Catheter Cardiovasc Interv, 76, 1047, 10.1002/ccd.22658

Lindholt, 2011, The Scandinavian Propaten Trial—1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses—a randomised clinical controlled multi-centre trial, Eur J Vasc Endovasc Surg, 41, 668, 10.1016/j.ejvs.2011.01.021

Rastan, 2011, Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial, Eur Heart J, 32, 2274, 10.1093/eurheartj/ehr144

Bosiers, 2012, Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease, J Vasc Surg, 55, 390, 10.1016/j.jvs.2011.07.099

Shammas, 2012, Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial, J Endovasc Ther, 19, 480, 10.1583/JEVT-12-3815MR.1

Baumann, 2013, Clinically-driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia, J Endovasc Ther, 20, 707, 10.1583/13-4375MR.1

Baumann, 2013, Clinically driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia, Vasa, 42, 57

Liistro, 2013, Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia, Circulation, 128, 615, 10.1161/CIRCULATIONAHA.113.001811

Lo, 2013, Outcomes following infrapopliteal angioplasty for critical limb ischemia, J Vasc Surg, 57, 1455, 10.1016/j.jvs.2012.10.109

McKinsey, 2014, Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study, JACC Cardiovasc Interv, 7, 923, 10.1016/j.jcin.2014.05.006

Singh, 2014, Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia, J Vasc Surg, 59, 1300, 10.1016/j.jvs.2013.11.061

Zeller, 2014, Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial, J Am Coll Cardiol, 64, 1568, 10.1016/j.jacc.2014.06.1198

Bosiers, 2015, The PES-BTK-70 study: final results of the assessment of the first self-expanding nitinol paclitaxel eluting stent in below-the-knee lesions, EuroIntervention

Lee, 2015, Impact of nitinol self-expanding stent on the patency of subintimal angioplasty for below-the-knee occlusions with critical limb ischemia (NEXSIA-BTK): multicenter, prospective registry, J Am Coll Cardiol, 66, B323, 10.1016/j.jacc.2015.08.1106

Rastan, 2015, One-year outcomes following directional atherectomy of infrapopliteal artery lesions: subgroup results of the prospective, multicenter DEFINITIVE LE trial, J Endovasc Ther, 22, 839, 10.1177/1526602815608610

Yiu, 2015, Primary stenting in femoropopliteal occlusive disease—what is the appropriate role?, Circ J, 79, 704, 10.1253/circj.CJ-15-0199

Yiu, 2015, The roles of drug-eluting technology and atherectomy in infrapopliteal occlusive disease, Ital J Vasc Endovasc Surg, 22, 1

Mustapha, 2016, Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis, Circ Cardiovasc Interv, 9, e003468, 10.1161/CIRCINTERVENTIONS.115.003468

Spreen, 2016, Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) trial, Circ Cardiovasc Interv, 9, e002376, 10.1161/CIRCINTERVENTIONS.114.002376

Spreen, 2017, Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia, J Am Heart Assoc, 6, e004877, 10.1161/JAHA.116.004877

Guzman, 2008, Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease, J Am Coll Cardiol, 51, 1967, 10.1016/j.jacc.2007.12.058

Kang, 2016, Semiquantitative assessment of tibial artery calcification by computed tomography angiography and its ability to predict infrapopliteal angioplasty outcomes, J Vasc Surg, 64, 1335, 10.1016/j.jvs.2016.04.047

Kawarada, 2012, Predictors of adverse clinical outcomes after successful infrapopliteal intervention, Catheter Cardiovasc Interv, 80, 861, 10.1002/ccd.24370

Haine, 2018, Patency of the arterial pedal-plantar arch in patients with chronic kidney disease or diabetes mellitus, Ther Adv Cardiovasc Dis, 12, 145, 10.1177/1753944718756605

Taylor, 2006, Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions, J Vasc Surg, 44, 747, 10.1016/j.jvs.2006.06.015

Arvela, 2010, Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia, J Vasc Surg, 52, 1218, 10.1016/j.jvs.2010.06.101

Moxey, 2013, The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores, J Vasc Surg, 57, 1, 10.1016/j.jvs.2012.04.074

Simons, 2018, Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization, J Vasc Surg

Kraiss, 2015, Frailty assessment in vascular surgery and its utility in preoperative decision making, Semin Vasc Surg, 28, 141, 10.1053/j.semvascsurg.2015.10.003

Kraiss, 2016, A Vascular Quality Initiative-based frailty instrument predicts 9-month postoperative mortality, J Vasc Surg, 64, 551, 10.1016/j.jvs.2016.05.038

Kodama, 2014, Clinical outcomes after infrainguinal bypass grafting for critical limb ischaemia in patients with dialysis-dependent end-stage renal failure, Eur J Vasc Endovasc Surg, 48, 695, 10.1016/j.ejvs.2014.08.022

Fallon, 2015, Outcomes of lower extremity revascularization among the hemodialysis-dependent, J Vasc Surg, 62, 1183, 10.1016/j.jvs.2015.06.203

Fleisher, 2014, 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines, J Am Coll Cardiol, 64, e77, 10.1016/j.jacc.2014.07.944

Kristensen, 2014, Eur Heart J, 35, 2383, 10.1093/eurheartj/ehu282

Pomposelli, 1990, Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations, J Vasc Surg, 11, 745, 10.1016/0741-5214(90)90069-M

Eiberg, 2004, In-situ bypass surgery on arteriographically invisible vessels detected by Doppler-ultrasound for limb salvage, J Cardiovasc Surg (Torino), 45, 375

Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy, J Vasc Surg, 51, 5S, 10.1016/j.jvs.2010.01.073

Korhonen, 2011, Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: a propensity score analysis, Eur J Vasc Endovasc Surg, 41, 378, 10.1016/j.ejvs.2010.11.025

Jones, 2014, Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia, Am Heart J, 167, 489, 10.1016/j.ahj.2013.12.012

Meltzer, 2016, Comparative effectiveness of peripheral vascular intervention versus surgical bypass for critical limb ischemia in the Vascular Study Group of Greater New York, J Vasc Surg, 64, 1320, 10.1016/j.jvs.2016.02.069

Siracuse, 2016, Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative, J Vasc Surg, 63, 958, 10.1016/j.jvs.2015.09.063

Pomposelli, 2003, A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases, J Vasc Surg, 37, 307, 10.1067/mva.2003.125

Dick, 2007, Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome, J Vasc Surg, 45, 751, 10.1016/j.jvs.2006.12.022

Fernandez, 2011, Multilevel versus isolated endovascular tibial interventions for critical limb ischemia, J Vasc Surg, 54, 722, 10.1016/j.jvs.2011.03.232

Antoniou, 2013, A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease, J Vasc Surg, 57, 242, 10.1016/j.jvs.2012.07.038

Baumann, 2013, Infrapopliteal lesion morphology in patients with critical limb ischemia: implications for the development of anti-restenosis technologies, J Endovasc Ther, 20, 149, 10.1583/1545-1550-20.2.149

Iida, 2013, Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up, Circ Cardiovasc Interv, 6, 68, 10.1161/CIRCINTERVENTIONS.112.975318

Saqib, 2013, Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia, J Vasc Surg, 57, 692, 10.1016/j.jvs.2012.08.115

Ballotta, 2014, Lower extremity arterial reconstruction for critical limb ischemia in diabetes, J Vasc Surg, 59, 708, 10.1016/j.jvs.2013.08.103

Iida, 2015, JACC Cardiovasc Interv, 8, 1493, 10.1016/j.jcin.2015.07.005

Brothers, 2016, Predicting outcomes for infrapopliteal limb-threatening ischemia using the Society for Vascular Surgery Vascular Quality Initiative, J Vasc Surg, 63, 114, 10.1016/j.jvs.2015.08.063

Okamoto, 2016, Impact of perioperative complications after endovascular therapy in diabetic patients with critical limb ischemia due to isolated infrapopliteal lesions, J Endovasc Ther, 23, 371, 10.1177/1526602816632712

Iida, 2017, Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia), Circ Cardiovasc Interv, 10, e005531, 10.1161/CIRCINTERVENTIONS.117.005531

Nakama, 2017, Clinical outcomes of pedal artery angioplasty for patients with ischemic wounds: results from the multicenter RENDEZVOUS registry, JACC Cardiovasc Interv, 10, 79, 10.1016/j.jcin.2016.10.025

Vogel, 2011, In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia, J Vasc Surg, 54, 109, 10.1016/j.jvs.2010.12.055

Nolan, 2011, Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass, J Vasc Surg, 54, 730, 10.1016/j.jvs.2011.03.236

Jones, 2013, Growing impact of restenosis on the surgical treatment of peripheral arterial disease, J Am Heart Assoc, 2, e000345, 10.1161/JAHA.113.000345

Faries, 2000, A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts, J Vasc Surg, 32, 1080, 10.1067/mva.2000.111279

Brochado Neto, 2014, Arm vein as an alternative autogenous conduit for infragenicular bypass in the treatment of critical limb ischaemia: a 15 year experience, Eur J Vasc Endovasc Surg, 47, 609, 10.1016/j.ejvs.2014.01.019

Armstrong, 2004, Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy, J Vasc Surg, 40, 724, 10.1016/j.jvs.2004.07.037

Taylor, 1987, The vascular territories (angiosomes) of the body: experimental study and clinical applications, Br J Plast Surg, 40, 113, 10.1016/0007-1226(87)90185-8

Attinger, 2006, Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization, Plast Reconstr Surg, 117, 261S, 10.1097/01.prs.0000222582.84385.54

Aerden, 2014, Wound morphology and topography in the diabetic foot: hurdles in implementing angiosome-guided revascularization, Int J Vasc Med, 2014, 6

Berceli, 1999, Efficacy of dorsal pedal artery bypass in limb salvage for ischemic heel ulcers, J Vasc Surg, 30, 499, 10.1016/S0741-5214(99)70077-7

Rashid, 2013, The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome, J Vasc Surg, 57, 1219, 10.1016/j.jvs.2012.10.129

Fusaro, 2013, Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials, JACC Cardiovasc Interv, 6, 1284, 10.1016/j.jcin.2013.08.007

Geraghty, 2013, Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease, J Vasc Surg, 58, 386, 10.1016/j.jvs.2013.01.050

Todd, 2013, Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia, J Vasc Surg, 58, 941, 10.1016/j.jvs.2013.04.024

Ambler, 2014, Atherectomy for peripheral arterial disease, Cochrane Database Syst Rev, 3, CD006680

Antoniou, 2014, Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?, Interact Cardiovasc Thorac Surg, 19, 282, 10.1093/icvts/ivu093

Fanelli, 2014, Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era, Eur Radiol, 24, 793, 10.1007/s00330-014-3094-0

Liu, 2017, Drug-eluting stents versus control therapy in the infrapopliteal disease: a meta-analysis of eight randomized controlled trials and two cohort studies, Int J Surg, 44, 166, 10.1016/j.ijsu.2017.06.075

Gandini, 2014, Pedal and plantar loop angioplasty: technique and results, J Cardiovasc Surg (Torino), 55, 665

Dorigo, 2011, A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics, J Vasc Surg, 54, 1332, 10.1016/j.jvs.2011.05.046

Uhl, 2017, Comparison of long-term outcomes of heparin bonded polytetrafluoroethylene and autologous vein below knee femoropopliteal bypasses in patients with critical limb ischaemia, Eur J Vasc Endovasc Surg, 54, 203, 10.1016/j.ejvs.2017.05.001

Neville, 2012, A comparison of tibial artery bypass performed with heparin-bonded expanded polytetrafluoroethylene and great saphenous vein to treat critical limb ischemia, J Vasc Surg, 56, 1008, 10.1016/j.jvs.2012.03.020

Cook, 1976, Vascular disease of extremities. Electric stimulation of spinal cord and posterior roots, N Y State J Med, 76, 366

Naoum, 2013, Spinal cord stimulation for chronic limb ischemia, Methodist Debakey Cardiovasc J, 9, 99, 10.14797/mdcj-9-2-99

1994

Jivegard, 1995, Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study, Eur J Vasc Endovasc Surg, 9, 421, 10.1016/S1078-5884(05)80010-3

Claeys, 1996, Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation, Int Angiol, 15, 344

Ubbink, 1999, Microcirculatory investigations to determine the effect of spinal cord stimulation for critical leg ischemia: the Dutch multicenter randomized controlled trial, J Vasc Surg, 30, 236, 10.1016/S0741-5214(99)70133-3

Spincemaille, 2000, Spinal cord stimulation in patients with critical limb ischernia: a preliminary evaluation of a multicentre trial, Acta Chir Austriaca, 32, 49, 10.1046/j.1563-2563.2000.00049.x

Amann, 2003, Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS), Eur J Vasc Endovasc Surg, 26, 280, 10.1053/ejvs.2002.1876

Klomp, 2006, Spinal cord stimulation is not cost-effective for non-surgical management of critical limb ischaemia, Eur J Vasc Endovasc Surg, 31, 500, 10.1016/j.ejvs.2005.11.013

Sanni, 2005, Is sympathectomy of benefit in critical leg ischaemia not amenable to revascularisation?, Interact Cardiovasc Thorac Surg, 4, 478, 10.1510/icvts.2005.115410

Barnes, 1977, Value of concomitant sympathectomy in aortoiliac reconstruction. Results of a prospective, randomized study, Arch Surg, 112, 1325, 10.1001/archsurg.1977.01370110059006

Cross, 1985, Chemical lumbar sympathectomy for ischemic rest pain. A randomized, prospective controlled clinical trial, Am J Surg, 150, 341, 10.1016/0002-9610(85)90075-3

Fyfe, 1975, Phenol sympathectomy in the treatment of intermittent claudication: a controlled clinical trail, Br J Surg, 62, 68, 10.1002/bjs.1800620116

Kim, 1976, Lumbar sympathectomy in end stage arterial occlusive disease, Ann Surg, 183, 157, 10.1097/00000658-197602000-00012

Collins, 1981, Clinical results of lumbar sympathectomy, Am Surg, 47, 31

Norman, 1988, The early use of operative lumbar sympathectomy in peripheral vascular disease, J Cardiovasc Surg (Torino), 29, 717

Baker, 1994, Operative lumbar sympathectomy for severe lower limb ischaemia: still a valuable treatment option, Ann R Coll Surg Engl, 76, 50

Alexander, 1994, Chemical lumbar sympathectomy in patients with severe lower limb ischaemia, Ulster Med J, 63, 137

Mashiah, 1995, Phenol lumbar sympathetic block in diabetic lower limb ischemia, J Cardiovasc Risk, 2, 467

Perez-Burkhardt, 1999, Lumbar sympathectomy as isolated technique for the treatment of lower limbs chronic ischemia, J Cardiovasc Surg (Torino), 40, 7

Holiday, 1999, Lumbar sympathectomy in critical limb ischaemia: surgical, chemical or not at all?, Cardiovasc Surg, 7, 200, 10.1016/S0967-2109(97)00094-X

Matarazzo, 2002, Possibilities at present for the application of lumbar sympathectomy in chronic occlusive arterial disease of the lower limbs, Minerva Cardioangiol, 50, 363

Pieri, 2005, Lumbar sympathectomy under CT guidance: therapeutic option in critical limb ischaemia, Radiol Med, 109, 430

Moran, 2015, A systematic review of intermittent pneumatic compression for critical limb ischaemia, Vasc Med, 20, 41, 10.1177/1358863X14552096

Labropoulos, 2002, Intermittent pneumatic compression for the treatment of lower extremity arterial disease: a systematic review, Vasc Med, 7, 141, 10.1191/1358863x02vm423oa

Kavros, 2008, Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up, J Vasc Surg, 47, 543, 10.1016/j.jvs.2007.11.043

Tawfick, 2013, Sequential compression biomechanical device versus primary amputation in patients with critical limb ischemia, Vasc Endovascular Surg, 47, 532, 10.1177/1538574413499413

Dillon, 1986, Treatment of resistant venous stasis ulcers and dermatitis with the end-diastolic pneumatic compression boot, Angiology, 37, 47, 10.1177/000331978603700108

Dillon, 1986, Successful treatment of osteomyelitis and soft tissue infections in ischemic diabetic legs by local antibiotic injections and the end-diastolic pneumatic compression boot, Ann Surg, 204, 643, 10.1097/00000658-198612000-00005

Steinberg, 1992, Cardiosynchronous limb compression: effects on noninvasive vascular tests and clinical course of the ischemic limb, Angiology, 43, 453, 10.1177/000331979204300601

van Bemmelen, 2001, Limb salvage using high-pressure intermittent compression arterial assist device in cases unsuitable for surgical revascularization, Arch Surg, 136, 1280, 10.1001/archsurg.136.11.1280

Louridas, 2002, The ArtAssist Device in chronic lower limb ischemia. A pilot study, Int Angiol, 21, 28

Montori, 2002, Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Clinic experience (1998-2000), Int Angiol, 21, 360

Sultan, 2011, Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease, J Vasc Surg, 54, 440, 10.1016/j.jvs.2011.02.057

Chang, 2012, Using intermittent pneumatic compression therapy to improve quality of life for symptomatic patients with infrapopliteal diffuse peripheral obstructive disease, Circ J, 76, 971, 10.1253/circj.CJ-11-1229

Setacci, 2011, Chapter IV: treatment of critical limb ischaemia, Eur J Vasc Endovasc Surg, 42, S43, 10.1016/S1078-5884(11)60014-2

Ruffolo, 2010, Prostanoids for critical limb ischaemia, Cochrane Database Syst Rev, 1, CD006544

Lambert, 2013, Medical management of critical limb ischaemia: where do we stand today?, J Intern Med, 274, 295, 10.1111/joim.12102

Creutzig, 2004, Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV, Vasa, 33, 137, 10.1024/0301-1526.33.3.137

Loosemore, 1994, A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease, Int Angiol, 13, 133

Belch, 2011, The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia, Int Angiol, 30, 150

1995, Intravenous pentoxifylline for the treatment of chronic critical limb ischaemia. The European Study Group, Eur J Vasc Endovasc Surg, 9, 426, 10.1016/S1078-5884(05)80011-5

1996, Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia. A placebo controlled multicenter study. Norwegian Pentoxifylline Multicenter Trial Group, Int Angiol, 15, 75

Miyashita, 2011, Cilostazol increases skin perfusion pressure in severely ischemic limbs, Angiology, 62, 15, 10.1177/0003319710371619

Soga, 2011, Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia, J Vasc Surg, 54, 1659, 10.1016/j.jvs.2011.06.024

Tonnesen, 1978, Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study, Scand J Clin Lab Invest, 38, 431, 10.3109/00365517809108447

Lowe, 1982, Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg, Angiology, 33, 46, 10.1177/000331978203300107

Stoekenbroek, 2014, Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review, Eur J Vasc Endovasc Surg, 47, 647, 10.1016/j.ejvs.2014.03.005

Murad, 2014, Using GRADE for evaluating the quality of evidence in hyperbaric oxygen therapy clarifies evidence limitations, J Clin Epidemiol, 67, 65, 10.1016/j.jclinepi.2013.08.004

Faglia, 1996, Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study, Diabetes Care, 19, 1338, 10.2337/diacare.19.12.1338

Abidia, 2003, The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial, Eur J Vasc Endovasc Surg, 25, 513, 10.1053/ejvs.2002.1911

Löndahl, 2010, Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes, Diabetes Care, 33, 998, 10.2337/dc09-1754

Löndahl, 2011, Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers, Diabetologia, 54, 65, 10.1007/s00125-010-1946-y

Margolis, 2013, Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study, Diabetes Care, 36, 1961, 10.2337/dc12-2160

Anderson, 2013, Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 127, 1425, 10.1161/CIR.0b013e31828b82aa

Lepantalo, 1996, Outcome of unreconstructed chronic critical leg ischaemia, Eur J Vasc Endovasc Surg, 11, 153, 10.1016/S1078-5884(96)80044-X

Slovut, 2008, Critical limb ischemia: medical and surgical management, Vasc Med, 13, 281, 10.1177/1358863X08091485

Elgzyri, 2013, Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention, Eur J Vasc Endovasc Surg, 46, 110, 10.1016/j.ejvs.2013.04.013

Nesargikar, 2009, Lumbar chemical sympathectomy in peripheral vascular disease: does it still have a role?, Int J Surg, 7, 145, 10.1016/j.ijsu.2009.01.004

Martini, 2012, Amputation rate and mortality in elderly patients with critical limb ischemia not suitable for revascularization, Aging Clin Exp Res, 24, 24

Isner, 1996, Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb, Lancet, 348, 370, 10.1016/S0140-6736(96)03361-2

Nikol, 2008, Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia, Mol Ther, 16, 972, 10.1038/mt.2008.33

Baumgartner, 2009, Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia, Mol Ther, 17, 914, 10.1038/mt.2009.24

Belch, 2011, Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia, Lancet, 377, 1929, 10.1016/S0140-6736(11)60394-2

Powell, 2010, Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial, J Vasc Surg, 52, 1525, 10.1016/j.jvs.2010.07.044

Powell, 2008, Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia, Circulation, 118, 58, 10.1161/CIRCULATIONAHA.107.727347

Shigematsu, 2010, Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia, Gene Ther, 17, 1152, 10.1038/gt.2010.51

Iafrati, 2011, Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia, J Vasc Surg, 54, 1650, 10.1016/j.jvs.2011.06.118

Murphy, 2011, Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia, J Vasc Surg, 53, 1565, 10.1016/j.jvs.2011.01.074

Iafrati, 2016, SS03. Bone marrow aspirate concentrate in critical limb ischemia: results of an abridged prospective randomized pivotal trial in no option CLI, J Vasc Surg, 63, 47S, 10.1016/j.jvs.2016.03.016

Murphy, 2016

Powell, 2012, Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial, Mol Ther, 20, 1280, 10.1038/mt.2012.52

Losordo, 2012, A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia, Circ Cardiovasc Interv, 5, 821, 10.1161/CIRCINTERVENTIONS.112.968321

Pignon, 2017, Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia—results of a randomized, double-blind, placebo-controlled trial, Circ J, 81, 1713, 10.1253/circj.CJ-17-0045

Teraa, 2015, Circulation, 131, 851, 10.1161/CIRCULATIONAHA.114.012913

Thom, 2016, Measurements of CD34+/CD45-dim stem cells predict healing of diabetic neuropathic wounds, Diabetes, 65, 86, 10.2337/db15-0517

Sheahan, 2005, Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization, J Vasc Surg, 42, 476, 10.1016/j.jvs.2005.05.003

Kadukammakal, 2012, Assessment of partial first-ray resections and their tendency to progress to transmetatarsal amputations, J Am Podiatr Med Assoc, 102, 412, 10.7547/1020412

Borkosky, 2013, Incidence of repeat amputation after partial first ray amputation associated with diabetes mellitus and peripheral neuropathy: an 11-year review, J Foot Ankle Surg, 52, 335, 10.1053/j.jfas.2013.02.004

Thorud, 2016, Reoperation and reamputation after transmetatarsal amputation: a systematic review and meta-analysis, J Foot Ankle Surg, 55, 1007, 10.1053/j.jfas.2016.05.011

Lavery, 1995, Increased foot pressures after great toe amputation in diabetes, Diabetes Care, 18, 1460, 10.2337/diacare.18.11.1460

Ballotta, 2009, Revascularization to an isolated (blind) popliteal artery segment: a viable procedure for critical limb ischemia, Surgery, 145, 426, 10.1016/j.surg.2008.12.005

Mohapatra, 2018, Heel wounds predict mortality but not amputation after infrapopliteal revascularization, Ann Vasc Surg, 51, 78, 10.1016/j.avsg.2017.11.072

Oliver, 2015, Lower extremity function following partial calcanectomy in high-risk limb salvage patients, J Diabetes Res, 2015, 7

Kodama, 2017, Association between preoperative frailty and mortality in patients with critical limb ischemia following infrainguinal bypass surgery—usefulness of the Barthel index, Circ J, 82, 267, 10.1253/circj.CJ-17-0369

Chopra, 2018, Ambulation and functional outcome after major lower extremity amputation, J Vasc Surg, 67, 1521, 10.1016/j.jvs.2017.10.051

Arsenault, 2012, The use of transcutaneous oximetry to predict healing complications of lower limb amputations: a systematic review and meta-analysis, Eur J Vasc Endovasc Surg, 43, 329, 10.1016/j.ejvs.2011.12.004

Dillingham, 2005, Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations, Arch Phys Med Rehabil, 86, 480, 10.1016/j.apmr.2004.06.072

Kono, 2012, Identifying the incidence of and risk factors for reamputation among patients who underwent foot amputation, Ann Vasc Surg, 26, 1120, 10.1016/j.avsg.2012.02.011

Beaulieu, 2015, Rates and predictors of readmission after minor lower extremity amputations, J Vasc Surg, 62, 101, 10.1016/j.jvs.2015.02.021

Landry, 2011, Predictors of healing and functional outcome following transmetatarsal amputations, Arch Surg, 146, 1005, 10.1001/archsurg.2011.206

Quigley, 2016, Quality of life in persons with partial foot or transtibial amputation: a systematic review, Prosthet Orthot Int, 40, 18, 10.1177/0309364614546526

O'Brien, 2013, Risk factors for early failure of surgical amputations: an analysis of 8,878 isolated lower extremity amputation procedures, J Am Coll Surg, 216, 836, 10.1016/j.jamcollsurg.2012.12.041

Waton, 2015

van Netten, 2016, Early post-operative mortality after major lower limb amputation: a systematic review of population and regional based studies, Eur J Vasc Endovasc Surg, 51, 248, 10.1016/j.ejvs.2015.10.001

Uzzaman, 2011, Assessing the long-term outcomes of minor lower limb amputations: a 5-year study, Angiology, 62, 365, 10.1177/0003319710395558

Wilbek, 2016, The diabetic foot in a multidisciplinary team setting. Number of amputations below ankle level and mortality, Exp Clin Endocrinol Diabetes, 124, 535, 10.1055/s-0042-109260

Subramaniam, 2005, Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics, Anesth Analg, 100, 1241, 10.1213/01.ANE.0000147705.94738.31

Fortington, 2013, Short and long term mortality rates after a lower limb amputation, Eur J Vasc Endovasc Surg, 46, 124, 10.1016/j.ejvs.2013.03.024

Inderbitzi, 2003, The long-term mobility and mortality of patients with peripheral arterial disease following bilateral amputation, Eur J Vasc Endovasc Surg, 26, 59, 10.1053/ejvs.2002.1868

Hoffmann, 2015, Survival of diabetes patients with major amputation is comparable to malignant disease, Diab Vasc Dis Res, 12, 265, 10.1177/1479164115579005

Karam, 2013, Predictors of operative mortality following major lower extremity amputations using the National Surgical Quality Improvement Program public use data, J Vasc Surg, 58, 1276, 10.1016/j.jvs.2013.05.026

Fisher, 1978, Energy cost of ambulation in health and disability: a literature review, Arch Phys Med Rehabil, 59, 124

Ali, 2013, A contemporary comparative analysis of immediate postoperative prosthesis placement following below-knee amputation, Ann Vasc Surg, 27, 1146, 10.1016/j.avsg.2012.10.031

Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4

Steinhubl, 2002, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial, JAMA, 288, 2411, 10.1001/jama.288.19.2411

Nguyen, 2005, Resistance to clopidogrel: a review of the evidence, J Am Coll Cardiol, 45, 1157, 10.1016/j.jacc.2005.01.034

Dörffler-Melly, 2005, Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment, Cochrane Database Syst Rev, 1, CD002071

Soden, 2016, Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization, J Vasc Surg, 64, 1633, 10.1016/j.jvs.2016.05.098

Iida, 2013, Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study, Circulation, 127, 2307, 10.1161/CIRCULATIONAHA.112.000711

Iftikhar, 2016, Prevention of femoropopliteal in-stent restenosis with cilostazol: a meta-analysis, Angiology, 67, 549, 10.1177/0003319715604768

Soga, 2017, Efficacy of CilostAzol for Below-the-Knee Artery Disease after Balloon AnGioplasty in PatiEnts with Severe Limb Ischemia (CABBAGE Trial), Ann Vasc Surg, 45, 22, 10.1016/j.avsg.2017.05.029

2000, Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial, Lancet, 355, 346, 10.1016/S0140-6736(99)07199-8

Johnson, 2002, Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study, J Vasc Surg, 35, 413, 10.1067/mva.2002.121847

Sarac, 1998, Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure, J Vasc Surg, 28, 446, 10.1016/S0741-5214(98)70130-2

Geraghty, 2011, Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery, Cochrane Database Syst Rev, 6, CD000536

Brumberg, 2007, The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure, J Vasc Surg, 46, 1160, 10.1016/j.jvs.2007.07.046

Mewissen, 2004, Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results, Tech Vasc Interv Radiol, 7, 2, 10.1053/j.tvir.2004.01.007

Duda, 2006, Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial, J Endovasc Ther, 13, 701, 10.1583/05-1704.1

Schillinger, 2007, Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting, Circulation, 115, 2745, 10.1161/CIRCULATIONAHA.107.688341

Laird, 2014, Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the Complete SE Multicenter Trial, J Endovasc Ther, 21, 202, 10.1583/13-4548R.1

Idu, 1993, Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience, J Vasc Surg, 17, 42, 10.1016/0741-5214(93)90008-A

Lundell, 1995, Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study, J Vasc Surg, 21, 26, 10.1016/S0741-5214(95)70241-5

Ihlberg, 1998, The utility of duplex scanning in infrainguinal vein graft surveillance: results from a randomised controlled study, Eur J Vasc Endovasc Surg, 16, 19, 10.1016/S1078-5884(98)80087-7

Ihlberg, 1999, Does a completely accomplished duplex-based surveillance prevent vein-graft failure?, Eur J Vasc Endovasc Surg, 18, 395, 10.1053/ejvs.1999.0935

Bandyk, 2002, Infrainguinal vein bypass graft surveillance: how to do it, when to intervene, and is it cost-effective?, J Am Coll Surg, 194, S40, 10.1016/S1072-7515(01)01117-6

Davies, 2005, Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST), Circulation, 112, 1985, 10.1161/CIRCULATIONAHA.104.518738

Baril, 2009, Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery, J Vasc Surg, 49, 133, 10.1016/j.jvs.2008.09.046

Saarinen, 2014, Duplex surveillance after endovascular revascularisation for critical limb ischaemia, Eur J Vasc Endovasc Surg, 47, 418, 10.1016/j.ejvs.2014.01.012

Armstrong, 2010, Surveillance after peripheral artery angioplasty and stenting, 169

Baril, 2013, Rationale and benefits of surveillance after percutaneous transluminal angioplasty and stenting of iliac and femoral arteries, 339

Mewissen, 1992, The role of duplex scanning versus angiography in predicting outcome after balloon angioplasty in the femoropopliteal artery, J Vasc Surg, 15, 860, 10.1016/0741-5214(92)90721-J

Spijkerboer, 1996, Evaluation of femoropopliteal arteries with duplex ultrasound after angioplasty. Can we predict results at one year?, Eur J Vasc Endovasc Surg, 12, 418, 10.1016/S1078-5884(96)80006-2

Kasirajan, 2001, Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia, J Vasc Interv Radiol, 12, 413, 10.1016/S1051-0443(07)61878-8

Sarac, 2004, Clinical and economic evaluation of the Trellis thrombectomy device for arterial occlusions: preliminary analysis, J Vasc Surg, 39, 556, 10.1016/j.jvs.2003.10.061

Sacks, 1994, The value of duplex sonography after peripheral artery angioplasty in predicting subacute restenosis, AJR Am J Roentgenol, 162, 179, 10.2214/ajr.162.1.8273660

Tielbeek, 1996, The value of duplex surveillance after endovascular intervention for femoropopliteal obstructive disease, Eur J Vasc Endovasc Surg, 12, 145, 10.1016/S1078-5884(96)80099-2

Mills, 1995, The origin of infrainguinal vein graft stenosis: a prospective study based on duplex surveillance, J Vasc Surg, 21, 16, 10.1016/S0741-5214(95)70240-7

Avino, 1999, Surgical and endovascular intervention for infrainguinal vein graft stenosis, J Vasc Surg, 29, 60, 10.1016/S0741-5214(99)70361-7

Abu Dabrh, 2017, Systematic review and meta-analysis of duplex ultrasound surveillance for infrainguinal vein bypass grafts, J Vasc Surg, 66, 1885, 10.1016/j.jvs.2017.06.113

Björkman, 2017, Peripheral vascular restenosis: a retrospective study on the use of drug-eluting balloons in native arteries, vein grafts and dialysis accesses, Scand J Surg, 106, 158, 10.1177/1457496916654098

Jongsma, 2017, Drug-eluting balloons and uncoated balloons perform equally to rescue infrainguinal autologous bypasses at risk, J Vasc Surg, 66, 454, 10.1016/j.jvs.2017.02.032

Dunlop, 1996, The effect of a surveillance programme on the patency of synthetic infrainguinal bypass grafts, Eur J Vasc Endovasc Surg, 11, 441, 10.1016/S1078-5884(96)80179-1

Aune, 1998, Surveillance of above-knee prosthetic femoropopliteal bypass, Eur J Vasc Endovasc Surg, 16, 509, 10.1016/S1078-5884(98)80242-6

Calligaro, 2001, Should duplex ultrasonography be performed for surveillance of femoropopliteal and femorotibial arterial prosthetic bypasses?, Ann Vasc Surg, 15, 520, 10.1007/s10016-001-0006-y

Mohler, 2012, J Am Coll Cardiol, 60, 242, 10.1016/j.jacc.2012.02.009

Stone, 2006, Duplex ultrasound criteria for femorofemoral bypass revision, J Vasc Surg, 44, 496, 10.1016/j.jvs.2006.06.002

Fitzgerald, 2009, The diabetic rapid response acute foot team: 7 essential skills for targeted limb salvage, Eplasty, 9, e15

Rogers, 2010, Toe and flow: essential components and structure of the amputation prevention team, J Vasc Surg, 52, 23S, 10.1016/j.jvs.2010.06.004

Armstrong, 2013, Juggling risk to reduce amputations: the three-ring circus of infection, ischemia and tissue loss-dominant conditions, Wound Med, 1, 13, 10.1016/j.wndm.2013.03.002

Pickwell, 2013, Diabetic foot disease: impact of ulcer location on ulcer healing, Diabetes Metab Res Rev, 29, 377, 10.1002/dmrr.2400

Armstrong, 2004, It's not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound, Clin Infect Dis, 39, S92, 10.1086/383269

Bus

Pappalardo, 2013, Wound healing simplification: a vertical and horizontal philosophy illustrated, J Wound Technol, 19, 38

Rose, 2014, Split-thickness skin grafting the high-risk diabetic foot, J Vasc Surg, 59, 1657, 10.1016/j.jvs.2013.12.046

Armstrong, 2017, Diabetic foot ulcers and their recurrence, N Engl J Med, 376, 2367, 10.1056/NEJMra1615439

Armstrong, 2006, Validation of a diabetic foot surgery classification, Int Wound J, 3, 240, 10.1111/j.1742-481X.2006.00236.x

Armstrong, 2007, Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients, Am J Med, 120, 1042, 10.1016/j.amjmed.2007.06.028

Arad, 2011, Beyond the monofilament for the insensate diabetic foot. A systematic review of randomized trials to prevent the occurrence of plantar foot ulcers in patients with diabetes, Diabetes Care, 34, 1041, 10.2337/dc10-1666

Ulbrecht, 2014, Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial, Diabetes Care, 37, 1982, 10.2337/dc13-2956

Cook, 2013, IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage, BMJ, 346, 10.1136/bmj.f2820

Ergina, 2013, IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages, BMJ : British Medical Journal, 346, f2820, 10.1136/bmj.f3011

Hirst, 2019, No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations, Ann Surg, 269, 211, 10.1097/SLA.0000000000002794

McCulloch, 2013, IDEAL framework for surgical innovation 1: the idea and development stages, BMJ, 346, f3012, 10.1136/bmj.f3012

Sedrakyan, 2016, IDEAL-D: a rational framework for evaluating and regulating the use of medical devices, BMJ, 353, i2372, 10.1136/bmj.i2372

Behrendt, 2018, International Consortium of Vascular Registries consensus recommendations for peripheral revascularisation registry data collection, Eur J Vasc Endovasc Surg, 56, 217, 10.1016/j.ejvs.2018.04.006

Bhatt, 2016, Adaptive designs for clinical trials, N Engl J Med, 375, 65, 10.1056/NEJMra1510061

Bothwell, 2016, The emergence of the randomized, controlled trial, N Engl J Med, 375, 501, 10.1056/NEJMp1604635

Avery, 2017, Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies, BMJ Open, 7, e013537, 10.1136/bmjopen-2016-013537

Bradbury, 2010, Health Technol Assess, 14, 1, 10.3310/hta14140

Nordanstig, 2014, Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease, J Vasc Surg, 59, 700, 10.1016/j.jvs.2013.08.099

Conte, 2006, Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery, J Vasc Surg, 43, 742, 10.1016/j.jvs.2005.12.058

Clark, 2002, Quantification of the completeness of follow-up, Lancet, 359, 1309, 10.1016/S0140-6736(02)08272-7

Clark, 2003, Survival analysis part I: basic concepts and first analyses, Br J Cancer, 89, 232, 10.1038/sj.bjc.6601118

von Allmen, 2015, Completeness of follow-up determines validity of study findings: results of a prospective repeated measures cohort study, PLoS One, 10, e0140817, 10.1371/journal.pone.0140817

Conte, 2015, Revascularization for chronic limb-threatening ischaemia, Br J Surg, 102, 1007, 10.1002/bjs.9848

Caro, 2005, The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database, BMC Cardiovasc Disord, 5, 14, 10.1186/1471-2261-5-14

Carls, 2011, The economic value of specialized lower-extremity medical care by podiatric physicians in the treatment of diabetic foot ulcers, J Am Podiatr Med Assoc, 101, 93, 10.7547/1010093

Chan, 2017, Cost-of-illness studies in chronic ulcers: a systematic review, J Wound Care, 26, S4, 10.12968/jowc.2017.26.Sup4.S4

Stockl, 2004, Costs of lower-extremity ulcers among patients with diabetes, Diabetes Care, 27, 2129, 10.2337/diacare.27.9.2129

Skrepnek, 2017, Health care service and outcomes among an estimated 6.7 million ambulatory care diabetic foot cases in the U.S, Diabetes Care, 40, 936, 10.2337/dc16-2189

Ü, 2016, Survival evaluation of the patients with diabetic major lower-extremity amputations, Musculoskelet Surg, 100, 145, 10.1007/s12306-016-0399-y

Robbins, 2008, Mortality rates and diabetic foot ulcers, J Am Podiatr Med Assoc, 98, 489, 10.7547/0980489

Sugerman, 2013, Centers of excellence, JAMA, 310, 994, 10.1001/jama.2013.277345

Rogers, 2010, Toe and flow, J Am Podiatr Med Assoc, 100, 342, 10.7547/1000342

Rogers, 2010, Podiatry care, 1747

Reiber, 1999, Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings, Diabetes Care, 22, 157, 10.2337/diacare.22.1.157

Pecoraro, 1990, Pathways to diabetic limb amputation. Basis for prevention, Diabetes Care, 13, 513, 10.2337/diacare.13.5.513

Rogers, 2011, The Charcot foot in diabetes, J Am Podiatr Med Assoc, 101, 437, 10.7547/1010437

Wukich, 2013, Inpatient management of diabetic foot disorders: a clinical guide, Diabetes Care, 36, 2862, 10.2337/dc12-2712

Snyder, 2014, The management of diabetic foot ulcers through optimal off-loading, J Am Podiatr Med Assoc, 104, 555, 10.7547/8750-7315-104.6.555

Hingorani, 2016, The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine, J Vasc Surg, 63, 3S, 10.1016/j.jvs.2015.10.003

Wrobel, 2006, The high-low amputation ratio: a deeper insight into diabetic foot care?, J Foot Ankle Surg, 45, 375, 10.1053/j.jfas.2006.09.015

Sanders, 2010, History of the team approach to amputation prevention: pioneers and milestones, J Vasc Surg, 52, 3S, 10.1016/j.jvs.2010.06.002

Van Gils, 1999, Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience, Diabetes Care, 22, 678, 10.2337/diacare.22.5.678

Wrobel, 2006, Diabetes-related foot care at 10 Veterans Affairs medical centers: must do’s associated with successful microsystems, Jt Comm J Qual Patient Saf, 32, 206

Driver, 2005, Reducing amputation rates in patients with diabetes at a military medical center. The Limb Preservation Service model, Diabetes Care, 28, 248, 10.2337/diacare.28.2.248

Armstrong, 2012, The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot, Diabetes Metab Res Rev, 28, 514, 10.1002/dmrr.2299

Sloan, 2010, Receipt of care and reduction of lower extremity amputations in a nationally representative sample of U.S. elderly, Health Serv Res, 45, 1740, 10.1111/j.1475-6773.2010.01157.x

Schmidt, 2017, Podiatry impact on high-low amputation ratio characteristics: a 16-year retrospective study, Diabetes Res Clin Pract, 126, 272, 10.1016/j.diabres.2017.02.008

van Houtum, 2004, Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000, Diabetes Care, 27, 1042, 10.2337/diacare.27.5.1042

Pedrosa, 2006, The diabetic foot in Brazil, 364

Anichini, 2007, Improvement of diabetic foot care after the implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study, Diabetes Res Clin Pract, 75, 153, 10.1016/j.diabres.2006.05.014

Rubio, 2014, Reducing major lower extremity amputations after the introduction of a multidisciplinary team for the diabetic foot, Int Low Extrem Wounds, 13, 22, 10.1177/1534734614521234

Canavan, 2008, Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care. Continuous longitudinal monitoring using a standard method, Diabetes Care, 31, 459, 10.2337/dc07-1159

Williams, 2018, Improved limb salvage for patients with vascular disease and tissue loss associated with new model of provision targeted at the diabetic foot, Diabetes Res Clin Pract, 135, 50, 10.1016/j.diabres.2017.10.015

Eskelinen, 2006, Major amputation incidence decreases both in non-diabetic and in diabetic patients in Helsinki, Scand J Surg, 95, 185, 10.1177/145749690609500311

Laakso, 2017, Re-organizing inpatient care saves legs in patients with diabetic foot infections, Diabetes Res Clin Pract, 125, 39, 10.1016/j.diabres.2017.01.007

Hirsch, 2013, The global pandemic of peripheral artery disease, Lancet, 382, 1312, 10.1016/S0140-6736(13)61576-7

Kapoor, 2017, Guidance on reuse of cardio-vascular catheters and devices in India: a consensus document, Indian Heart J, 69, 357, 10.1016/j.ihj.2017.04.003

Katsanos, 2018, Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials, J Am Heart Assoc, 7e011245

de Graaff, 2001, Interobserver and intraobserver reproducibility of peripheral blood and oxygen pressure measurements in the assessment of lower extremity arterial disease, J Vasc Surg, 33, 1033, 10.1067/mva.2001.108011

Wang, 2016, A systematic review and meta-analysis of tests to predict wound healing in diabetic foot, J Vasc Surg, 63, 29S, 10.1016/j.jvs.2015.10.004

Brownrigg, 2016, Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review, Diabetes Metab Res Rev, 32, 119, 10.1002/dmrr.2703

Beropoulis, 2016, Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia, J Vasc Surg, 64, 95, 10.1016/j.jvs.2016.01.040

Ward, 2017, Outcomes of critical limb ischemia in an urban, safety net hospital population with high WIfI amputation scores, Ann Vasc Surg, 38, 84, 10.1016/j.avsg.2016.08.005

Darling, 2016, Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia, J Vasc Surg, 64, 616, 10.1016/j.jvs.2016.03.417

Lijmer, 1996, ROC analysis of noninvasive tests for peripheral arterial disease, Ultrasound Med Biol, 22, 391, 10.1016/0301-5629(96)00036-1

Aboyans, 2008, The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects, J Vasc Surg, 48, 1197, 10.1016/j.jvs.2008.06.005

Salaun, 2018, Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART cohort, Angiology

Larch, 1997, Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography, J Vasc Surg, 25, 629, 10.1016/S0741-5214(97)70288-X

Visser, 2000, Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US—a meta-analysis, Radiology, 216, 67, 10.1148/radiology.216.1.r00jl0367

Adriaensen, 2004, Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations, Radiology, 233, 385, 10.1148/radiol.2331031595

Collins, 2007, Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review, BMJ, 334, 1257, 10.1136/bmj.39217.473275.55

Hingorani, 2004, A comparison of magnetic resonance angiography, contrast arteriography, and duplex arteriography for patients undergoing lower extremity revascularization, Ann Vasc Surg, 18, 294, 10.1007/s10016-004-0039-0

Hingorani, 2008, Limitations of and lessons learned from clinical experience of 1,020 duplex arteriography, Vascular, 16, 147, 10.2310/6670.2008.00014

Met, 2009, Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis, JAMA, 301, 415, 10.1001/jama.301.4.415

1997, Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities, Eur J Vasc Endovasc Surg, 14, 91

Faglia, 2014, Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an observational study, Diabetes Res Clin Pract, 103, 292, 10.1016/j.diabres.2013.12.060

Armstrong, 2014, Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease, J Am Heart Assoc, 3, e000697, 10.1161/JAHA.113.000697

2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71

Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1

1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3

Hiatt, 2017, Ticagrelor versus clopidogrel in symptomatic peripheral artery disease, N Engl J Med, 376, 32, 10.1056/NEJMoa1611688

Anand, 2018, Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial, Lancet, 391, 219, 10.1016/S0140-6736(17)32409-1

Anand, 2007, Oral anticoagulant and antiplatelet therapy and peripheral arterial disease, N Engl J Med, 357, 217, 10.1056/NEJMoa065959

Mills, 2011, Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients, Eur Heart J, 32, 1409, 10.1093/eurheartj/ehr035

2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3

Meade, 2002, Bezafibrate in men with lower extremity arterial disease: randomised controlled trial, BMJ, 325, 1139, 10.1136/bmj.325.7373.1139

Leng, 2000, Lipid-lowering for lower limb atherosclerosis, Cochrane Database Syst Rev, 2, CD000123

Aung, 2007, Lipid-lowering for peripheral arterial disease of the lower limb, Cochrane Database Syst Rev, 4, CD000123

Rodriguez, 2017, Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease, JAMA Cardiol, 2, 47, 10.1001/jamacardio.2016.4052

Wright, 2015, A randomized trial of intensive versus standard blood-pressure control, N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939

Bavry, 2010, Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy, Hypertension, 55, 48, 10.1161/HYPERTENSIONAHA.109.142240

Cushman, 2010, Effects of intensive blood-pressure control in type 2 diabetes mellitus, N Engl J Med, 362, 1575, 10.1056/NEJMoa1001286

Moise, 2016, Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: the Cardiovascular Disease Policy Model, Hypertension, 68, 88, 10.1161/HYPERTENSIONAHA.115.06814

Nathan, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 353, 2643, 10.1056/NEJMoa052187

van Dieren, 2014, Intensification of medication and glycaemic control among patients with type 2 diabetes—the ADVANCE trial, Diabetes Obes Metab, 16, 426, 10.1111/dom.12238

Selvin, 2004, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus, Ann Intern Med, 141, 421, 10.7326/0003-4819-141-6-200409210-00007

Palmer, 2016, Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis, JAMA, 316, 313, 10.1001/jama.2016.9400

Nawaz, 1998, Clinical risk associated with contrast angiography in metformin treated patients: a clinical review, Clin Radiol, 53, 342, 10.1016/S0009-9260(98)80005-6

Goergen, 2010, Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin, Radiology, 254, 261, 10.1148/radiol.09090690

Blomster, 2016, The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial, BMJ Open, 6, e009668, 10.1136/bmjopen-2015-009668

Newhall, 2017, Impact and duration of brief surgeon-delivered smoking cessation advice on attitudes regarding nicotine dependence and tobacco harms for patients with peripheral arterial disease, Ann Vasc Surg, 38, 113, 10.1016/j.avsg.2016.06.005

Athyros, 2013, The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study, Curr Vasc Pharmacol, 11, 779, 10.2174/1570161111311050016

Dagenais, 2005, Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial, Eur J Cardiovasc Prev Rehabil, 12, 75, 10.1177/204748730501200112

Kondo, 2011, Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers, Circ J, 75, 2885, 10.1253/circj.CJ-11-0416

Schanzer, 2008, Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data, J Vasc Surg, 48, 1464, 10.1016/j.jvs.2008.07.062

Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making, J Vasc Surg, 51, 52S, 10.1016/j.jvs.2010.01.077

Meltzer, 2013, The Comprehensive Risk Assessment for Bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia, J Vasc Surg, 57, 1186, 10.1016/j.jvs.2012.09.083

Simons, 2016, A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass, J Vasc Surg, 63, 990, 10.1016/j.jvs.2015.09.051

Biancari, 2007, Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study, World J Surg, 31, 217, 10.1007/s00268-006-0242-y

Lavery, 2008, Prediction of healing for postoperative diabetic foot wounds based on early wound area progression, Diabetes Care, 31, 26, 10.2337/dc07-1300

Sheehan, 2003, Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial, Diabetes Care, 26, 1879, 10.2337/diacare.26.6.1879

Snyder, 2010, A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks, Ostomy Wound Manage, 56, 44

Cardinal, 2008, Early healing rates and wound area measurements are reliable predictors of later complete wound closure, Wound Repair Regen, 16, 19, 10.1111/j.1524-475X.2007.00328.x

Abu Dabrh, 2015, The natural history of untreated severe or critical limb ischemia, J Vasc Surg, 62, 1642, 10.1016/j.jvs.2015.07.065

Cull, 2014, An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system, J Vasc Surg, 60, 1535, 10.1016/j.jvs.2014.08.107

Zhan, 2015, The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing, J Vasc Surg, 61, 939, 10.1016/j.jvs.2014.11.045

Darling, 2015, VESS16. Predictive ability of the SVS Lower Extremity Guidelines Committee Wound, Ischemia, and Foot Infection (WIfI) scale for first-time revascularizations, J Vasc Surg, 61, 24S, 10.1016/j.jvs.2015.04.042

Causey, 2016, Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program, J Vasc Surg, 63, 1563, 10.1016/j.jvs.2016.01.011

Robinson, 2017, Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center, J Vasc Surg, 66, 488, 10.1016/j.jvs.2017.01.063

Seeger, 1987, Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery, Ann Surg, 205, 733, 10.1097/00000658-198706000-00016

Wengerter, 1990, Influence of vein size (diameter) on infrapopliteal reversed vein graft patency, J Vasc Surg, 11, 525, 10.1016/0741-5214(90)90297-N

Schanzer, 2007, Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial, J Vasc Surg, 46, 1180, 10.1016/j.jvs.2007.08.033

Harward, 1995, Limb-threatening ischemia due to multilevel arterial occlusive disease. Simultaneous or staged inflow/outflow revascularization, Ann Surg, 221, 498, 10.1097/00000658-199505000-00007

Zukauskas, 1995, Sequential aortofemoropopliteal/distal bypass for treatment of critical lower-limb ischaemia, Cardiovasc Surg, 3, 671, 10.1016/0967-2109(96)82868-7

Jongkind, 2010, A systematic review of endovascular treatment of extensive aortoiliac occlusive disease, J Vasc Surg, 52, 1376, 10.1016/j.jvs.2010.04.080

Ye, 2011, Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions, J Vasc Surg, 53, 1728, 10.1016/j.jvs.2011.02.005

Deloose, 2017, Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results, J Cardiovasc Surg (Torino), 58, 416

Indes, 2013, Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis, J Endovasc Ther, 20, 443, 10.1583/13-4242.1

Chiu, 2010, Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease, Eur J Vasc Endovasc Surg, 39, 460, 10.1016/j.ejvs.2009.12.014

Ricco, 2008, Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease, J Vasc Surg, 47, 45, 10.1016/j.jvs.2007.08.050

Kang, 2008, Common femoral artery occlusive disease: contemporary results following surgical endarterectomy, J Vasc Surg, 48, 872, 10.1016/j.jvs.2008.05.025

Ballotta, 2010, Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study, Surgery, 147, 268, 10.1016/j.surg.2009.08.004

Chang, 2008, Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease, J Vasc Surg, 48, 362, 10.1016/j.jvs.2008.03.042

Baumann, 2011, Endovascular treatment of common femoral artery obstructions, J Vasc Surg, 53, 1000, 10.1016/j.jvs.2010.10.076

Bonvini, 2011, Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures, J Am Coll Cardiol, 58, 792, 10.1016/j.jacc.2011.01.070

Gouëffic, 2017, Stenting or surgery for de novo common femoral artery stenosis, JACC Cardiovasc Interv, 10, 1344, 10.1016/j.jcin.2017.03.046

Siracuse, 2016, Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative, J Vasc Surg, 63, 958, 10.1016/j.jvs.2015.09.063

Almasri, 2018, A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia, J Vasc Surg, 68, 624, 10.1016/j.jvs.2018.01.066

Chae, 2016, Is angiosome-targeted angioplasty effective for limb salvage and wound healing in diabetic foot? A meta-Analysis, PLoS One, 11, e0159523, 10.1371/journal.pone.0159523

Jongsma, 2017, Angiosome-directed revascularization in patients with critical limb ischemia, J Vasc Surg, 65, 1208, 10.1016/j.jvs.2016.10.100

Biancari, 2014, Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis, Eur J Vasc Endovasc Surg, 47, 517, 10.1016/j.ejvs.2013.12.010

Sumpio, 2013, Clinical implications of the angiosome model in peripheral vascular disease, J Vasc Surg, 58, 814, 10.1016/j.jvs.2013.06.056

Azuma, 2012, Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?, Eur J Vasc Endovasc Surg, 43, 322, 10.1016/j.ejvs.2011.12.001

Schillinger, 2006, Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Engl J Med, 354, 1879, 10.1056/NEJMoa051303

Saxon, 2008, Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease, J Vasc Interv Radiol, 19, 823, 10.1016/j.jvir.2008.02.008

Dake, 2011, Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results, Circ Cardiovasc Interv, 4, 495, 10.1161/CIRCINTERVENTIONS.111.962324

Rosenfield, 2015, Trial of a paclitaxel-coated balloon for femoropopliteal artery disease, N Engl J Med, 373, 145, 10.1056/NEJMoa1406235

Mills, 1992, Contribution of routine intraoperative completion arteriography to early infrainguinal bypass patency, Am J Surg, 164, 506, 10.1016/S0002-9610(05)81190-0

Bandyk, 1994, Intraoperative duplex scanning of arterial reconstructions: fate of repaired and unrepaired defects, J Vasc Surg, 20, 426, 10.1016/0741-5214(94)90142-2

Ubbink, 2013, Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia, Cochrane Database Syst Rev, 2, CD004001

Karanth, 2016, Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease, Cochrane Database Syst Rev, 12, CD011519

Abu Dabrh, 2015, Nonrevascularization-based treatments in patients with severe or critical limb ischemia, J Vasc Surg, 62, 1330, 10.1016/j.jvs.2015.07.069

Vietto, 2018, Prostanoids for critical limb ischaemia, Cochrane Database Syst Rev, 1, CD006544

Smith, 2012, Intravenous naftidrofuryl for critical limb ischaemia, Cochrane Database Syst Rev, 7, CD002070

Kranke, 2015, Hyperbaric oxygen therapy for chronic wounds, Cochrane Database Syst Rev, 6, CD004123

Game, 2016, Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review, Diabetes Metab Res Rev, 32, 154, 10.1002/dmrr.2707

Santema, 2018, Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial, Diabetes Care, 41, 112, 10.2337/dc17-0654

Peeters Weem, 2015, Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials, Eur J Vasc Endovasc Surg, 50, 775, 10.1016/j.ejvs.2015.08.018

Elsherif, 2018, Quality of time spent without symptoms of disease or toxicity of treatment for transmetatarsal amputation versus digital amputation in diabetic patients with digital gangrene, Vascular, 26, 142, 10.1177/1708538117718108

Siracuse, 2015, Impact of "do not resuscitate" status on the outcome of major vascular surgical procedures, Ann Vasc Surg, 29, 1339, 10.1016/j.avsg.2015.05.014

Aziz, 2015, The influence of do-not-resuscitate status on the outcomes of patients undergoing emergency vascular operations, J Vasc Surg, 61, 1538, 10.1016/j.jvs.2014.11.087

Reed, 2008, Major lower extremity amputation after multiple revascularizations: was it worth it?, Ann Vasc Surg, 22, 335, 10.1016/j.avsg.2007.07.039

Rollins, 1985, Isolated profundaplasty for limb salvage, J Vasc Surg, 2, 585, 10.1016/0741-5214(85)90014-X

Miksic, 1986, Profunda femoris revascularization in limb salvage, J Cardiovasc Surg (Torino), 27, 544

Ayoub, 1993, Thru-knee amputation: the operation of choice for non-ambulatory patients, Am Surg, 59, 619

Taylor, 2008, "Successful outcome" after below-knee amputation: an objective definition and influence of clinical variables, Am Surg, 74, 607, 10.1177/000313480807400707

Webster, 2012, Prosthetic fitting, use, and satisfaction following lower-limb amputation: a prospective study, J Rehabil Res Dev, 49, 1493, 10.1682/JRRD.2012.01.0001

Glaser, 2013, Fate of the contralateral limb after lower extremity amputation, J Vasc Surg, 58, 1571, 10.1016/j.jvs.2013.06.055

Bradley, 2006, Secondary prevention of arteriosclerosis in lower limb vascular amputees: a missed opportunity, Eur J Vasc Endovasc Surg, 32, 491, 10.1016/j.ejvs.2006.07.005

Bedenis, 2015, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, 2, CD000535

Abbruzzese, 2004, Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts, J Vasc Surg, 39, 1178, 10.1016/j.jvs.2003.12.027

Henke, 2004, Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality, J Vasc Surg, 39, 357, 10.1016/j.jvs.2003.08.030

Suckow, 2015, Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival, J Vasc Surg, 61, 126, 10.1016/j.jvs.2014.05.093

Brown, 2008, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, 4, CD000535

Willigendael, 2005, Smoking and the patency of lower extremity bypass grafts: a meta-analysis, J Vasc Surg, 42, 67, 10.1016/j.jvs.2005.03.024

Hobbs, 2003, Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach, Eur J Vasc Endovasc Surg, 26, 341, 10.1016/S1078-5884(03)00356-3

Belch, 2010, Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial, J Vasc Surg, 52, 825, 10.1016/j.jvs.2010.04.027

Gassman, 2014, Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency, Vascular, 22, 105, 10.1177/1708538112473977

Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989

Cassar, 2005, Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty, Br J Surg, 92, 159, 10.1002/bjs.4810

Strobl, 2013, Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease, J Endovasc Ther, 20, 699, 10.1583/13-4275MR.1

Tepe, 2012, Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial, Eur Radiol, 22, 1998, 10.1007/s00330-012-2441-2

Mills, 2001, The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair, J Vasc Surg, 33, 273, 10.1067/mva.2001.112701

Landry, 2002, Long-term outcome of revised lower-extremity bypass grafts, J Vasc Surg, 35, 56

Nguyen, 2004, Infrainguinal vein bypass graft revision: factors affecting long-term outcome, J Vasc Surg, 40, 916, 10.1016/j.jvs.2004.08.038

Bui, 2012, The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance, J Vasc Surg, 55, 346, 10.1016/j.jvs.2011.08.010

Humphries, 2011, Early duplex scanning after infrainguinal endovascular therapy, J Vasc Surg, 53, 353, 10.1016/j.jvs.2010.08.045

Elraiyah, 2016, A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers, J Vasc Surg, 63, 46S, 10.1016/j.jvs.2015.10.007